SlideShare a Scribd company logo
٠| P a g e
١| P a g e
٢| P a g e
٣| P a g e
‫آ‬ ‫ا‬‫ا‬
‫ا‬
‫ا‬‫ا‬‫ع‬ ‫ا‬‫واء‬ ‫رى‬ ‫ا‬ ‫ا‬
benzocaine-1
)‫ر‬(
benzydamine-2
hydrochl
‫ب‬ ‫د‬
cetalkonium-3
‫ان‬ ‫آ‬ ‫ت‬ ‫و‬ !" # ‫د‬
$ %‫وا‬ & !'# ( ) * "+ )
‫ا‬ , - ‫ى‬ ‫ا‬
‫ت‬ & /0# ‫د‬ ‫آ‬ ‫ا‬ %‫ا‬
‫م‬ 2&
‫ث‬ + 4
‫ات‬
" &
/
‫ر‬ ‫و‬
5 0 ‫ا‬ 6 27-
–‫و‬ ( '*
‫ت‬ "# ‫ا‬
"4‫ا‬ 6 ‫ا‬
$ 9
‫ب‬ -‫ا‬.
*< =9& -
‫ل‬ 0?
@2 ‫ا‬ ‫ر‬ '‫آ‬ ‫او‬
9.5
‫ت‬ "9A
‫خ‬
spray
B.B.C
benzocaine-1
)‫ر‬(
clove oil-2
( 07 C ‫ا‬ D &‫ز‬–/
5 F0 ‫وح‬ #
@")
" &
@! 2
5 - ‫ر‬ ‫و‬
‫ن‬ 9%-‫ا‬
1.5
‫ت‬ "9A
5‫ه‬Dentocalm
clove oil-1
(07 C ‫ا‬ D&‫ز‬–‫وح‬ # /
5 F0
geranium-2
" ‫ا‬ & ‫ا‬ & 6)
lidocaine-3
)‫ر‬(
@")
" &
5 - @!2
‫ن‬ 9%-‫ا‬
3.50
‫ت‬ "9A
#I‫ل‬Clovacaine
٤| P a g e
benzocaine-1
)‫ر‬(
( ‫آ‬١٢
K %
(‫ا-آ‬
‫ن‬ 9% ‫ر‬2‫ت‬ "9A5‫ه‬Dentocaine
Jojoba oil-1
( ) * ‫و‬ ‫ت‬ ‫د‬
‫ع‬ 2& ‫و‬ & !' ‫ا‬ @ ‫اع‬ 7-
M, - ‫وح‬ 6 ‫ا‬ ‫م‬ N ‫إ‬ P ,
F/# 7‫أ‬ P ‫إ‬
lidocaine-2
)‫ر‬(
@")
" &
‫ر‬ ‫و‬ /
5 0 ‫ا‬ 6 27-–
‫ج‬
‫ت‬ ‫ا‬
‫ا‬
‫ت‬ ‫آ‬ ‫ا‬
‫ا‬
5
‫ت‬ "9A
gelJogel
aminacrine-1
(used as a topical
antiseptic)
lidocaine-2
)‫ر‬(
@")
" &
50# /
‫ر‬ ‫و‬
7‫ت‬ "9AgelMedijel
cetalkonium-1
‫ان‬ ‫آ‬ ‫ت‬ ‫و‬ !" # ‫د‬
‫ى‬ ‫ا‬ $%‫وا‬ & !'# () * "+ )
‫د‬ ‫آ‬ ‫ا‬ %‫ا‬ ‫ا‬ , -
‫ت‬ & /0#
(‫آ‬ K A
١٢K %
R *
627
50# / ‫و‬
6‫ت‬ "9A(AMundisal
٦| P a g e
anthraquinone-1
glycoside
‫وب‬ !" ‫ا‬ #K C&
50 ‫ا‬ 4 C T2 ‫ا‬
lidocaine-2
)‫ر‬(
salicylic acid-3
‫ب‬ ) ‫د‬ ‫و‬ 5 @!2
٣‫ات‬
" &
$% ! #
‫وح‬ "" ‫"%ج‬" ‫و‬
‫ا‬
5‫ت‬ "9A‫ن‬ ‫ده‬Salivex-l
anthraquinone-1
glycoside
T2 ‫ا‬ ‫وب‬ !" ‫ا‬ #K C&
4 C50 ‫ا‬
menthole-2
M I_‫را‬ ‫ر‬ "? D &‫ز‬
F 0 ‫ة‬Z " M & /K
‫-ت‬ 4‫ن‬ C 4-‫ا‬ (`.
salicylic acid-3
‫ب‬ ) ‫د‬ ‫و‬ 5 @!2
@")
" &
$% ! #
‫وح‬ ‫%ج‬ ‫و‬
‫ا‬
5‫ت‬ "9A‫ن‬ ‫ده‬piravex
lidocaine-1
)‫ر‬(
aminoacridine-2
(used clinically as a
)antiseptictopical
salicylic acid-3
@!2‫د‬ ‫و‬ 5‫ب‬
@")
" &
$% ! #
‫وح‬ ‫%ج‬ ‫و‬
‫ا‬
7.5
‫ت‬ "9A
gelSeptogel
٧| P a g e
lidocaine-1
)‫ر‬(
cetyl pyredinium-2
chloride
thatantisepticIt is an
kills bacteria and other
microorganisms
Chloroceresol-3
‫دة‬ ‫آ‬ ‫دة‬ ‫ا‬ ‫ه‬ ‫#"م‬ $
‫ات‬ %& $ ‫ا‬ '( ‫ذاذات‬ *
' +, ‫ا‬ - " ‫ا‬
@")
" &
),-
‫ر‬ .-‫و‬
4.5
‫ت‬ "9A
gelcanyon
Active Ingredients
Amlexanox...............2
mg
(anti-inflammatory
antiallergic
immunomodulator used
to treat recurrent
aphthous ulcers (canker
sores),)
Inactive Ingredients
Microcrystalline
cellulose, Carbomer,
(‫آ‬ K A
١٢K %
(‫ا-آ‬
‫م‬ 2&
‫ح‬ * ‫ج‬
5 0 ‫ا‬
P #
@ @"c ' ‫ا‬
‫ا‬١٢
`‫آ‬d , M9 %
‫م‬ 2& -‫و‬
( *‫أ‬ ‫ل‬ 0?e
@١٢M9 %
P # ‫أو‬
M K 9 ‫ذوى‬
M" "'? "g
40‫ت‬ "9A‫اص‬ *‫ا‬Alpthtabn
lidocaine-1
)‫ر‬(
jojoba oil-2
*It possesses microbial
properties which
discourage the growth
of bacteria and fungal
microbes
*The oil also contains
nutrients such as
vitamin E, B complex
vitamins, and minerals
such as silicon,
@")
" &
50# /
‫ر‬ ‫و‬
5‫ت‬ "9AgelJobadel
٨| P a g e
1-menthol
‫ع‬ 9 9 ‫ا‬ D&‫ز‬ @ % %‫ا‬ ‫ن‬ !
F "0 5 26 ‫ا‬ #K $ &
‫ن‬ C 4-‫ا‬
2- thymol
= ‫ا‬ @ ‫ج‬ 2) j‫د‬
‫د‬ ‫وه‬ / ‫آ‬ ‫م‬ 2)‫و‬
‫ت‬ & /0#
3-sodium fluride
(Fluoride has been
found to be helpful in
reducing the number of
cavities in the teeth)
Saccharine sodium-4
, #I ‫ا‬ "6 ‫ا‬ 5 / ‫ا‬ , -
50 ‫ا‬
5- Glycerin +
Deionized water.
50# T?
@")
" &
*""" """),-
! """""""""""""""""#‫و‬
$%.
*‫رب‬ """"""""""""""12
3‫ا‬ """"""""""""""" ‫ا‬
4""""" 5 6""""" ‫ا‬
""""" ‫ا‬ """""17‫را‬
""""""""""""""""""""""""" 8
‫ب‬ """"""""""""8 ‫ا‬
) 9.
*‫رب‬ """"""""""""""12
""""""""""""""""" 5
‫"4%ك‬"""""""""""""""""""" ‫ا‬
6""" """ ‫وا‬
‫ن‬ ‫ا‬.
*6"" <9 ""12
‫ظ‬ """ !‫و‬ """9 >$
‫ن‬ ‫ا‬.
9.75
‫ت‬ "9A
orovex
chlorhexidine-1
100mHCL125mg
used in disinfectants
and Active substance
in healing wound
9K
‫وم‬Z# ‫ا‬
‫ث‬ + 4
‫ات‬
" &
),-
! #‫و‬
$%
3‫ت‬ "9AHexitol
٩| P a g e
cetrimide25%-1
?‫د‬ -‫ا‬ ), ‫م‬ . 5 ? ),-
‫ال‬ B-fungs‫و‬microbs
lidocaine-2
)6 D -‫ر‬ .-(
3-sodium fluride
(Fluoride has been found
to be helpful in reducing
the number of cavities in
the teeth)
‫ث‬ +
‫ات‬
" &
*""" """),-
! """""""""""""""""#‫و‬
$%
*"""""" ‫ا‬ """"""
‫ن‬ ‫وا‬
1.30
‫ت‬ "9A
Citrolin-F
1-Povidone iodine
200mg
‫ة‬ """ - ،‫ة‬ """),- G""" 9 ‫ذات‬ ‫دة‬ """-
G"" , ‫ا‬ ‫وق‬ ""1 ‫وا‬ ‫وح‬ "" ‫ا‬ "
G" ‫و‬K" ‫ا‬ G"2 ‫ا‬ ‫ت‬ "! ) ‫ا‬
3‫ا‬ """"""" ‫ا‬ )44""""""" 5)"""""""2 L4 ‫ا‬(
‫ت‬ 2 , ‫وا‬
K A
j 4‫وا‬
" &
*<=9& -
‫ا‬ %
‫ء‬ 9+‫ا‬
( I ‫ا‬
‫ب‬ ) ‫ا‬ ‫%ج‬
‫ا‬ ‫وى‬ ‫و‬
3.20
‫ت‬ "9A
Betadine Mw
1-menthol
‫ع‬ 9 9 ‫ا‬ D &‫ز‬ @ % %‫ا‬ ‫ن‬ !
F "0 5 26 ‫ا‬ #K $ &
‫ن‬ C 4-‫ا‬
clove oil-2
(07 C ‫ا‬ D&‫ز‬–‫وح‬ # /
‫د‬ ‫و‬ 5 F0
3-thymol
‫م‬ 2)‫و‬ = ‫ا‬ @ ‫ج‬ 2) j‫د‬
‫آ‬‫ت‬ & /0# ‫د‬ ‫وه‬ /
4-glycrein
50# T?
@")
" &
$% ! #
‫"%ج‬""""""""""""""""" ‫و‬
"" ‫ا‬ ‫وح‬ ""
""" N """),-‫و‬
$%.
3.75
‫ت‬ "9A
Oracin
١٠| P a g e
1-menthol
‫ع‬ 9 9 ‫ا‬ D&‫ز‬ @ % %‫ا‬ ‫ن‬ !
F"0 526 ‫ا‬ #K $ &
‫ن‬ C 4-‫ا‬
2-methyl salisylate
0.06%
3-eucalyptol
eucalyptol is used in
flavorings, fragrances,
and cosmetics
3-sodium fluride
(Fluoride has been found
to be helpful in reducing
the number of cavities in
the TEETH)
@")
" &
""""" """""),-
! """""""""""""""""#‫و‬
$%
4.90
‫ت‬ "9A
oradent
1-menthol
‫ع‬ " ‫ا‬ O"2‫ز‬ B"- 6" ‫ا‬ ‫ن‬ L-
Q"""" . """" ‫ا‬ 6"""" R""""D 2
‫ن‬ ‫ا‬
clove oil-2
S"" $ ‫ا‬ O""2‫ز‬–‫وح‬ "". ""),-
K3‫ا‬ ‫د‬ +-‫و‬ % Q .-
3-cinnamon
‫ت‬ """! ) ‫ا‬ """19 L- 6"""9 """ 5
2 L4 ‫وا‬ 2 , ‫ا‬
4-methyl paraben
*an anti-fungal agent
often used in a variety
of cosmetics and
personal-care
products.
*It is also used as a
food preservative
" & j),-
! #‫و‬
$%
4.25
‫ت‬ "9A
Ora-zed
١١| P a g e
1-BENZYDAMINE
0.15%
is a locally-acting
nonsteroidal anti-
inflammatory drug with
local anaesthetic and
analgesic properties for
pain relief and anti-
inflammatory treatment
of inflammatory
conditions of the mouth
9K
‫وم‬Z# ‫ا‬
4٣
‫ات‬
),-
! #‫و‬
$%
2.5
‫ت‬ "9A
TANTUM
VERDE
HEXETIDINE 0.1%
IT Is an anti-bacterial
and anti-fungal agent
commonly used in both
veterinary and human
medicine. It is a local
anesthetic, astringent
and deodorant and has
antiplaque effects.[
(‫آ‬١٢
K %
50# /
R *‫و‬
627
5‫ت‬ "9AORALDENE
1-CHLOHEXIDINE
used in disinfectants
2- Sodium citrate
used as an acidity
regulator in drinks
3- sodium borate
used in biochemical and
chemical laboratories to
make buffers
@")
" &
50# /
R *‫و‬
627
14.75
‫ت‬ "9A
LYSOPLAC
١٢| P a g e
S """""""" 2‫ود‬ ‫ا‬ """""""" -‫و‬ !
S""""""""""" U - 67 """"""""""" 3)٢
S""""""""""" 3‫إ‬ 6""""""""""" ‫آ‬ 9(
‫م‬ """"" $ -‫أ‬= )""""" -‫و‬ !
B -‫و‬ """"""""""""""""""""""""""""""""" ‫ا‬((((
، ‫ل‬ """"" - ، ‫ل‬ 4 """""‫آ‬ 2
S"""""#Z! ، ‫ى‬ """"" U2‫إ‬ O"""""2‫ز‬
G""""" L - ‫ت‬ """"" ‫آ‬....
‫ص‬ """""# S""""" ‫اغ‬ """""]
‫1%ب‬ """"""""""""""""""""""""""""""" ^....
‫اص‬ """""""#‫أ‬‫1%ب‬ """"""" ^
""")!٠`٥""" -‫و‬ ! """ -
6"""""""""" 2 B -‫و‬ """""""""" ‫ا‬
B -‫و‬ """""""" ‫ا‬ """""""" -‫و‬ !
‫ت‬ """4‫آ‬ - G""" - 6""" ‫إ‬
G""""""" ! ‫ا‬ ‫م‬ """"""" $ -b‫ا‬
G ‫ا‬ G 2 c....
G ‫ا‬
*1 2 ‫ادورال‬ !
6c . ‫ا‬ ‫ء‬ de ‫ا‬
‫ا‬ N.Q , c ‫و‬
+2‫أ‬ ‫ل‬ cb‫ا‬ 1 2....
67 # ‫ا‬ ‫ام‬ . ^
*‫وا‬ ‫ص‬ #
‫1%ب‬ ^٤-٦
، - 2 ‫ات‬ -‫اب‬i2
‫ا‬ 69 j,4!....
‫ت‬ 1 ‫ا‬ 69 ‫ام‬ . ^
% 9 ‫وى‬ ! G! k ‫ا‬::::
*‫وا‬ ‫ص‬ # 1 2
B 6 ‫إ‬ G S‫آ‬
)6k#‫أ‬ 1!٨‫اص‬ #‫أ‬
‫م‬ ‫ا‬ 69 ‫1%ب‬ ^((((....
m 1 ‫وا‬ ),-
‫م‬ . 2 ‫أ‬ 2 n ‫ذ‬ R-‫و‬
‫ر‬ )d ‫ا‬ ‫ء‬ 3‫أ‬ ‫ادورال‬ !
‫إ‬ S 1 ‫ا‬ B- 6 ‫و‬b‫ا‬ G3%U ‫ا‬
G2 )# ‫ب‬ 4 b....
) N3.75‫اص‬ #‫أ‬
14TABS
‫1%ب‬ ‫ا‬
BradoralBradoralBradoralBradoral
1-lysozym
10mg
2-dequalinium
25mg
*‫وا‬ ‫ص‬ #
‫1%ب‬ ^٤-٦
‫اب‬i2 ، - 2 ‫ات‬ -
‫ا‬ 69 j,4!
m 1 ‫وا‬ ),-) N‫ت‬ 9‫اص‬ #‫أ‬
20TABS
‫1%ب‬ ‫ا‬
laryprolaryprolaryprolarypro
١٣| P a g e
1-dichlorobenzyl
alchol
,antisepticmild
able to kill
andbacteria
associatedviruses
with mouth and
.infectionsthroat
2-amylmetacresol
antiseptican
used to treat
ofinfections
mouththe
throatand
*‫وا‬ ‫ص‬ #
‫1%ب‬ ^٤-٦
2 ‫ات‬ -‫اب‬i2 ، -
‫ا‬ 69 j,4!
‫ب‬ """"""""""") o ‫ول‬b‫ا‬ S"""""""""""
‫ة‬ 1 ‫وا‬ m 1 ‫ا‬
‫ات‬p""""""" ‫ا‬:*‫اص‬ """""""#‫أ‬
""""""""""""""2 L4 ‫دة‬ """"""""""""""+-
‫ة‬ 1 ‫ة‬ ),-
*""""" ),5 6""""" """"" 5
""""""""""""""""> 5‫و‬ Q""""""""""""""""$b‫ا‬
r ‫ا‬
*‫ة‬ """""""""""),- ‫اص‬ """""""""""#‫أ‬
G"""""""""""""" ‫وإزا‬ ‫ة‬ """""""""""""" 1
""""""""""""""""""" ‫ا‬ ‫ب‬ """"""""""""""""""") ‫إ‬
‫ة‬ 1 ‫وا‬
) N‫ت‬ 22‫اص‬ #‫أ‬
20TABS
‫1%ب‬ ‫ا‬
StrepsilsStrepsilsStrepsilsStrepsils
١٤| P a g e
١٥| P a g e
Nicomethanole
hydroflouride
A I ‫ا‬ T24 #K‫ن‬ ‫ا‬ S 511.50‫ت‬ "9AToothpast
e
‫ن‬ 9%‫ا‬ ‫ن‬ 6
‫ن‬ 9%
% 2I ‫ا‬
EGYFLUOR
gel,paste Many
flour
N 1 ‫ا‬ 6‫ن‬ ‫ا‬ S 521‫ت‬ "9AToothpast
e
‫ن‬ 9%‫ا‬ ‫ن‬ 6
‫ن‬ 9 %
% 2I ‫ا‬
Sensodyne
100gm
12‫ت‬ "9A
Sensodyne
55gm
١٦| P a g e
١٧| P a g e
Vit C- 2 ? ‫وا‬ ? -, `# ‫ا‬ Im #K ‫ظ‬ 0I#
`# ‫ا‬ F&Z7 4
@& !) "# K , K 2&
9 ‫ا‬ ‫ء‬ +‫ا‬ ‫ن‬ 9%-‫ا‬
8.00‫ت‬ "9A‫اص‬ #‫أ‬
20TABS
amovit-c
1000
Vit C- 2 ? ‫وا‬ ? -, K 2&‫و‬ `# ‫ا‬ & C)
‫ن‬ 9%-‫ا‬ @& !) "# K
4.00‫ت‬ "9A‫اص‬ #‫أ‬
20TABSCevarol
500mg
Vit C- 2 ? ‫وا‬ ? -, K 2&‫و‬ `# ‫ا‬ & C)
‫ن‬ 9%-‫ا‬ @& !) "# K
‫ـ‬
، ‫ا‬ ‫ج‬ ‫إ‬
‫ي‬ ‫ا‬ ‫و‬ ‫وا‬
‫ن‬ !‫ا‬ " #
$ % #&
،‫م‬ %( ‫ا‬ ،$) ‫ا‬ ،‫ن‬ *+,‫ا‬
12.00
‫ت‬ "9A
‫ار‬ 9Vitacid-c1g
١٨| P a g e
١٩| P a g e
chymotrypsin
+ trypsin
‫م‬p$ L ‫ا‬
‫ه‬‫ت‬ 2p$‫ا‬
proteolytic
‫ت‬ 5‫و‬ 4 ‫ا‬ L !
)$‫ا‬ m2 c B
‫ال‬ K 3Z !
exudative
phaseB-
inflamation
- 5 Sk1 49
Speptidic
chainsK !‫و‬
‫ن‬ L ‫ه‬ t 9
inflamation
‫ص‬ #٣- 2 ‫ات‬ -
)G ! S‫آ‬b‫ا‬ S4#(
B-‫و‬‫دة‬ 2‫ز‬ BL ‫ا‬
G 1 ‫ا‬ G ‫ا‬
١-‫ن‬ ‫ا‬ R w !
٢-U ‫ا‬ ‫ت‬ ! ) ‫ا‬
٣-‫ن‬ ‫وا‬ ‫ا‬ ‫ت‬ ! ) ‫ا‬
٤-‫ا‬ N ‫اى‬ !
‫او‬ n""""""" ‫ا‬ ‫او‬ """"""" ‫ا‬ 6"""""""9
‫ن‬ ‫ا‬
15‫ت‬ "9A‫اص‬ #‫أ‬
20TABS
Ambezim-g
chymotrypsin
+ trypsin
‫ص‬ #٣- 2 ‫ات‬ -
)G ! S‫آ‬b‫ا‬ S4#(
BL ‫ا‬ B-‫و‬‫دة‬ 2‫ز‬
G 1 ‫ا‬ G ‫ا‬
١-‫ن‬ ‫ا‬ R w !
٢-U ‫ا‬ ‫ت‬ ! ) ‫ا‬
٣-‫ن‬ ‫وا‬ ‫ا‬ ‫ت‬ ! ) ‫ا‬
٤-‫ا‬ N ‫اى‬ !
‫او‬ n""""""" ‫ا‬ ‫او‬ """"""" ‫ا‬ 6"""""""9
‫ن‬ ‫ا‬
20‫ت‬ "9A‫اص‬ #‫أ‬
20TABS
Alphintern
٢٠| P a g e
chymotrypsin
+ trypsin
1 ---- 2222- 2 G 4-‫أ‬
B 1 ‫ا‬ m2 c B
6 .5 ‫ان‬ 6 ‫إ‬ 6 + ‫ا‬
G D ‫ا‬ ‫اض‬ b‫ا‬....
••••‫ت‬ 1 ‫ا‬ 69
G -p ‫ا‬:١-٢6 ‫إ‬
٣4 ‫أ‬ ‫ات‬ -....
‫ت‬ 69 G- G k!
# ‫ى‬i ‫ا‬ 6 D ‫ا‬ ‫رم‬ ‫ا‬
G ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ 6 2
18‫ت‬ "9A5‫او‬ B
‫ت‬ 4-‫ا‬
Alpha
Chymotrypsin
1-THIOTEX
ACID 300MG
o" ‫آ‬ "` R 4
١_B2 L5 p 12
)S-k ‫ا‬ B2 L5(
S ] 5 B- B 12 n i
‫ب‬ k ‫ا‬
2-B- B 12
B $ ‫ا‬ B2 L5
B2 L5 m2 c
R ‫ا‬
‫%و‬)‫اوآ‬
B N‫و‬(
DOSE : in severe
cases 300-600 mg.
- by iv. Injection
daily for two to
four weeks, after
that oral tablets
should be used as
300 mg daily as a
maintenance dose.
*I ‫ا‬ , ‫اص‬ *-‫ا‬
j 4‫وا‬ j &‫د‬ ‫ا‬
‫ر‬ /0 ‫ا‬
pC, ‫ب‬ =K-‫ا‬ ‫ب‬ ‫ا‬26‫ت‬ "9A‫اص‬ #‫أ‬
20TABS
THIOTEX
300MG
30‫ت‬ "9A‫اص‬ #‫أ‬
20TABS
THIOTEX
600MG
٢١| P a g e
٢٢| P a g e
‫آ‬ ‫ا‬‫ا‬ ‫ا‬‫ا‬‫ا‬‫ع‬ ‫ا‬‫واء‬ ‫رى‬ ‫ا‬ ‫ا‬
1-metronidazol
& !'# ‫دة‬
M"_‫ا‬ ‫ه‬ ‫ا‬
*One of the
antibiotic that
kill bacteria by
in hibition of
nuclic acid OF
BACTERIA
30*" ‫آ‬ S"L -
S""""""" , ‫ا‬ ‫وزن‬ B""""""-
*K"""" !S"""" c """"
"""$‫وز‬ G """ ? """
١٠"""""42 5 """"" ‫آ‬.
*K""""""""""""""""""""""" 42٣٠
K""""9 G!‫و‬ """"+-١٠
‫وي‬ "" 2٣٠٠"" -
"""""""""""""""""""""""""""""""""" - 2.
*‫اب‬ """"d ‫ا‬ p"""" ‫آ‬ 5‫و‬
١٢٥S""""L """" -٥
S"""""""""""""""""""""""""""""""""""""""-:
*S"‫آ‬ ‫أذا‬5"! K" -
٥"""""""""""""""""""""""""""""""" -
‫ازول‬ """"""""""""" $‫و‬ -.
*‫م‬ . """""""" 2 ‫أذا‬١٢
B""""""- """""" - 2 S""""""-
S"""""""""""""""""""""""""""""" N%9.
*‫أي‬٤S-٣‫ات‬ -
- 2
*‫ن‬ 9%-‫ا‬ ‫وي‬ K)‫أذا‬
& !' ‫وي‬ K D7 ‫آ‬
M"_‫ا‬ ‫-ه‬(
*M & ! ‫ا‬ 50 ‫ا‬ MI_‫را‬
& !' ‫ا‬ T'2
M"_‫ا‬ ‫ه‬ ‫ا‬.
6‫ت‬ "9A
‫اص‬ *‫أ‬
20
TABS
Flagyl 500mg
.505
‫ت‬ "9A‫اص‬ *‫أ‬
20
TABS
Flagyl 250mg
04.5
‫ت‬ "9A
‫اب‬ rFlagyl 125mg
*U07
T"‫آ‬ ‫ا‬
F 2 ‫ا‬
K 6 ‫ا‬ U07
) C 2 ‫ا‬
*‫وي‬ K‫ن‬ 9%-‫ا‬)‫أذا‬
& !' ‫وي‬ K D7 ‫آ‬
M"_‫ا‬ ‫-ه‬(
*M & ! ‫ا‬ 50 ‫ا‬ MI_‫را‬
& !' ‫ا‬ T'2
M"_‫ا‬ ‫ه‬ ‫ا‬.
2.90"9A‫اص‬ *‫أ‬
20
Flagicure forte
500mg
1.60
"9A
‫اص‬ *‫أ‬
20
TABS
Flagicure 250mg
٢٣| P a g e
1-amoxycillin
2-flucloxacillin
‫ن‬ & "4 ‫دان‬ ‫ه‬
‫ا‬s‫وه‬"#K , p"# ‫ا‬
‫ج‬ K , " K
‫ت‬ ‫و‬ !" ‫وى‬ ‫ا‬
' 2 ‫وا‬ 'A ‫ا‬
‫ام‬ 6 ‫ا‬ c'= ‫ا‬.
*@"##"% 2‫آ‬ #‫آ‬ #0 ‫ا‬
flucloxacillin)(
‫ى‬ * "+ )
j‫ز‬ 0 ‫ا‬ ‫ت‬ ‫و‬ !" ‫ا‬
5&Z7-Z"9"##"29
penicillinase
*‫ل‬ 0? ‫و‬ ‫ر‬ '!#
‫ق‬ ,١٨K
2'‫آ‬500mg
(‫آ‬٦-٨‫او‬ ‫ت‬ K %
‫ص‬ *1g(‫آ‬١٢
j r T24 K %
‫وى‬ ‫ا‬
*4 ‫ل‬ 0?-‫ا‬١٠
‫ات‬ 9%١٢٥56-
٢٥٠(‫آ‬ (٨
‫ت‬ K %
*‫ن‬ 9%-‫ا‬ ‫وي‬ K
50 ‫وا‬)'A & !' ‫ا‬
‫ام‬ 6 ‫ا‬ ' %‫و‬ ‫ام‬ 6 ‫ا‬
"_‫ا‬ ‫ه‬ ‫ا‬ & !' ‫وا‬(
*‫وح‬ 6 ‫ا‬ ‫ث‬ #)
M"4‫ا‬ 6 ‫ا‬ ‫ت‬ "# ‫ا‬
7.5
‫ت‬ "9A
‫اص‬ *‫أ‬
20
TABS
Flumox 250 mg
18‫ت‬ "9A
20
TABS
‫اص‬ *‫ا‬
Flumox 500 mg
24‫ت‬ "9A
‫اص‬ *‫أ‬
20
TABS
Flumox 1G
13‫ت‬ "9A‫اب‬ rFlumox 100 (
T"‫آ‬ ‫ا‬ U07K 6 ‫ا‬ U07*‫ن‬ 9%-‫ا‬ ‫وي‬ K50 ‫وا‬
)'A & !' ‫ا‬
‫ام‬ 6 ‫ا‬ ' %‫و‬ ‫ام‬ 6 ‫ا‬
"_‫ا‬ ‫ه‬ ‫ا‬ & !' ‫وا‬(
*‫وح‬ 6 ‫ا‬ ‫ث‬ #)
M"4‫ا‬ 6 ‫ا‬ ‫ت‬ "# ‫ا‬
6‫ت‬ ) NFlumox 1G
٢٤| P a g e
@"##"2"2‫آ‬ ‫أ‬
"%‫أ‬ o"9" ", ‫.وآ‬
@ @"##"2"2‫آ‬ v‫ا‬
7‫أ‬ ‫وف‬ ‫ا‬
‫ت‬ 6 ‫ض‬ &
‫ن‬ !, ‫م‬ ‫-آ‬ "' ‫ا‬
‫د‬ A‫و‬ ‫وي‬ ‫ا‬ @
‫دة‬‫ر‬ C) M ,
‫ع‬ 9 ‫ا‬ ‫ا‬s‫ه‬ 4‫د‬ P#K
‫وم‬ C ‫ا‬ & !' ‫ا‬ @
j‫ود‬ @"##29'#
‫ن‬ !"‫ه‬
"%‫أ‬ o"9" ", ! ‫.ا‬
Clavulinic acid
‫ر‬ 4L ‫اص‬ #b‫:ا‬
625 ١٠٠٠(‫آ‬ 56
١٢‫ة‬ MK %٧‫م‬ &‫أ‬
M# ‫آ‬
*‫ن‬ 9%-‫ا‬ ‫وي‬ K50 ‫وا‬
)'A & !' ‫ا‬
‫ام‬ 6 ‫ا‬ ' %‫و‬ ‫ام‬ 6 ‫ا‬
"_‫ا‬ ‫ه‬ ‫ا‬ & !' ‫وا‬(
*6 ‫ا‬ ‫ث‬ #)‫وح‬
M"4‫ا‬ 6 ‫ا‬ ‫ت‬ "# ‫ا‬
58‫ت‬ "9A‫اص‬ *‫أ‬
14TAB
S
Augmentin1g
35‫ت‬ "9A‫اص‬ *‫أ‬
10TAB
S
Augmentin625
mg
375‫ت‬ "9A‫اص‬ *‫أ‬
10TAB
S
Augmentin375
mg
11.5‫ت‬ "9A9C4
Augmentin600
mg
T"‫آ‬ ‫ا‬ U07‫ل‬ c{ ‫اب‬ d ‫ا‬:
B-١-٦‫ات‬:
50*@ 56
Z"‫آ‬ )@"##2"2‫آ‬ -‫ا‬
P#K M 2C 56‫آ‬ (!
M+ + ‫أو‬ @" K A.
*7‫وز‬ (0? P9
١٢y & 56‫آ‬٤(
Z"‫آ‬ ) @٣١٢M+ +
" & ‫ات‬.
B- K ‫أ‬٦‫ات‬:
5*‫ات‬ M+ + (
Z"‫آ‬ ) @ " &
٤٥٧
‫ام‬ %-‫ا‬ U0728‫ت‬ "9A‫اب‬ r
Augmentin312
mg/5ml
37‫ت‬ "9A‫اب‬ r
Augmentin457
mg/5ml
٢٥| P a g e
T"‫آ‬ ) U07
‫ال‬
Augmenti
n
‫ر‬ '!# ‫اص‬ *v‫*ا‬
625 mg (‫آ‬١٢j٧‫م‬ &‫ا‬
*(‫آ‬ ‫او‬١٢K %١‫ام‬ A
j & z ‫ا‬ ‫وى‬ ‫ا‬ 4 ,
‫ب‬
*‫ن‬ 9%-‫ا‬ ‫وي‬ K
50 ‫وا‬)& !' ‫ا‬
‫ام‬ 6 ‫ا‬ 'A
‫ام‬ 6 ‫ا‬ ' %‫و‬
& !' ‫وا‬
"_‫ا‬ ‫ه‬ ‫ا‬(
*‫ث‬ #)‫وح‬ 6 ‫ا‬
M"4‫ا‬ 6 ‫ا‬ ‫ت‬ "# ‫ا‬
*6) 9 ‫ا‬ ‫ت‬ -‫ا‬
& !' ‫ا‬ @K)T ‫ا‬
`# ‫ا‬(
25‫ت‬ "9A‫اص‬ *‫أ‬
8 TABS
Hibiotic 1g
26‫ت‬ "9A‫اص‬ *‫أ‬
10 TABS
Hibiotic 625mg
19‫ت‬ "9A‫اص‬ *‫أ‬
10 TABS
Hibiotic 375mg
U07
T"‫آ‬ ‫ا‬
B-١-٦‫ات‬
50@ 56Z"‫آ‬ )
56‫آ‬ (! @"##2"2‫آ‬ -‫ا‬
‫أو‬ @" K A P#K M 2C
M+ +.
7‫وز‬ (0? P9١٢56‫آ‬
y &٤Z"‫آ‬ ) @ (٣٢٠
٣" & ‫ات‬
B- K ‫أ‬٦‫ات‬:
5(٣@ " & ‫ات‬
Z"‫آ‬ )٤٦٠.
@ '‫أآ‬ (0/ ‫ا‬ ‫وزن‬ ‫ن‬ ‫آ‬ ‫اذا‬
٤٠‫ر‬ '! ‫ا‬ MK A syd& 56‫آ‬
‫ام‬ %-‫ا‬ U07‫ت‬ "9A23‫اب‬ rHibiotic 460mg
‫ت‬ "9A32‫اب‬ rHibiotic 460mg
٢٦| P a g e
‫ز‬p1- ‫ص‬ # S‫آ‬
6 ‫ى‬ 12
B ‫آ‬ -‫أ‬
‫رات‬ ‫ه‬ ‫اى‬ 5
‫آ‬ ‫آ‬ 9‫و‬
‫م‬ 2‫د‬ ] B
‫رات‬ ‫ه‬ $ -
‫دل‬ 2:
-B ‫آ‬ -‫أ‬
500-
‫آ‬ ‫آ‬ 9
B2500-
B e 4 ‫ا‬
*(‫آ‬ ‫ص‬ *٨@! &‫و‬ ‫ت‬ K %
(‫آ‬ / & ‫ان‬٦, ‫ت‬ K %
j & z ‫ا‬ m-‫ا‬ 4
B B- ‫ل‬ c% ‫ا‬
١٦-٨
*(‫آ‬ ‫ص‬ * F=7 / &٨
/ & ‫ان‬ @! &‫و‬ ‫ت‬ K %
(‫آ‬ ‫ص‬ * F=7٦‫ت‬ K %
`‫ا-آ‬ m-‫ا‬ 4 ,
j‫ر‬ /y
١-‫ن‬ ‫ا‬ ‫اج‬ w
٢-U ‫ا‬ ‫ب‬ ) ‫ا‬
٣-‫وى‬ ‫ا‬
2 L4 ‫ا‬
‫ت‬ "9A 20‫اص‬ *‫أ‬
10 TABSFloxamo
1 M"#K , 5A
"2‫دروآ‬ 0"%
‫ل‬
‫ج‬ ‫دة‬ ‫ا‬ MK 6 ‫ا‬
‫ب‬ ‫ا‬50 ‫ا‬ 627‫وا‬ ‫ن‬ 9%-‫وا‬
‫ه‬١‫ة‬ 4‫وا‬ MK 6‫آ‬ ‫ام‬ A
#K M 2C ‫او‬ ‫م‬ " ‫ا‬ ,
‫ة‬ @" &‫و‬ 2 @" K A١٠
(*-‫ا‬ #K ‫م‬ &‫ا‬
*‫وى‬
‫ن‬ ‫وا‬ ‫ا‬
‫ت‬ "9A 8‫اص‬ *‫أ‬
8 TABS
Curisafe
٢٧| P a g e
Amoxycillin as
250mg, 500mg and
1000mg injections.
‫وى‬ ‫ا‬ 69
2 L4 ‫ا‬
*G 4‫آ‬٥٠٠-
S‫آ‬٨‫ت‬
*B 4‫آ‬٥٠٠
S‫آ‬ -١٢G
2 # ‫ا‬ 69
‫م‬ . 5
*9C4١‫ر‬ '!# ‫ام‬ A
*9C4500‫ام‬ 6
‫ل‬ 0?
(for mor
information
visit this web)
http://www.me
dsafe.govt.nz/pr
ofs/datasheet/i/i
biamoxinj.pdf
*prevent
blood
infection
due to
procedures
such as
dental
extractions
in patients
who are at
risk of
developing
endocarditi
s
*S4# ‫م‬ . 5
‫ن‬ ‫ا‬ R w
B- 2 #
endocarditi
s
6D - 69
6 1 ‫ا‬
-p5 -‫و‬ ‫ا‬
& !' ‫ا‬ ‫وى‬ ‫ا‬
*
"9A 3.70‫اص‬ *‫أ‬
12
TABS
IBIAMOX25
0 mg
"9A 8.00‫اص‬ *‫أ‬
12
TABS
IBIAMOX50
0 mg
٢٨| P a g e
٢٩| P a g e
@" `" ‫و‬ ) ‫رو-ك‬ "‫آ‬٣٠
56 Ketorolac
tromethamin
‫م‬p $ L ‫وا‬ ‫اص‬ . ‫:ا‬
‫-ك‬ "‫آ‬MK 6 P ‫إ‬ P 9&
"g ‫ت‬ |‫ا‬ ‫دات‬
M&‫ود‬ " 2 ‫ا‬ NSAIDs o s ‫و‬
P &Z7‫إ‬ p"'`) P#K (" & ,
‫ز‬ 9"6"2‫اوآ‬ #!"%١‫و‬٢
(COX-1+COX-2)
‫ق‬ ?-‫ا‬ P#K ‫اه‬ *‫ا‬ ' &‫.و‬
B 1 ‫ا‬ N
O15 B e 4٦٠-:
‫-ك‬ "‫آ‬@") @C4
P=*‫ا‬ I " &٤
C4‫ة‬ ‫و‬ " & @
‫ي‬ =* ‫ام‬ %‫إ‬٥&‫أ‬‫م‬
‫ال‬ ‫ق‬ 9٦٠-:
‫-ك‬ "‫آ‬ ‫ل‬ ' ‫أ‬ F=7
I " & @")
P=*‫أ‬٤" & @C4
‫ي‬ =* ‫ام‬ %‫إ‬ ‫ة‬ ‫و‬
٥pC, ‫م‬ &‫أ‬
‫ى‬ # BL -
‫ن‬ ‫وا‬ ‫ا‬
"9A 10‫اص‬ *‫أ‬
20
TABS
Ketolac
10 "9A5 @C4Ketolac
‫م‬ 5 ! ‫ك‬ 9 L2‫.د‬
Diclofenac
Potassium
25-50@ 56
(‫آ‬ ‫ص‬ *‫أ‬ ‫م‬ , ‫آ‬٨
‫ت‬ K %.
‫ول‬ ! |k 2‫و‬
! ‫اص‬ #‫أ‬ ‫9%م‬ ‫آ‬
? 3Z ‫ت‬ 4N ‫ا‬
‫ة‬ ‫ا‬ K.
-‫ن‬ b‫ا‬ ‫م‬ ‫ا‬
GU ‫وا‬.
"9A 5‫اص‬ *‫أ‬
10TABCata lam50mg
9"9A‫اص‬ *‫أ‬
10
TABS
Cata lam25mg
‫ي‬ I) M'#K A &
P#K٣‫-ت‬ ' ‫أ‬
P#K ‫ي‬ I) M'#K‫و‬٦
% ‫-ت‬ ' ‫أ‬
9 (‫آ‬ P, M ' -‫ا‬
٤}٧M ' e "9A.
@C4Cataflam75mg
٣٠| P a g e
‫ك‬ 9 L2‫د‬
‫م‬ 5 !.
Diclofenac
Potassium
B e 4 ‫ا‬:
‫أو9%م‬ ‫ل‬ ‫إ‬ 2٥٠
‫اص‬ #‫أ‬٣‫ات‬ -- 2
G2 # ‫ت‬ 4N ‫ا‬ !
‫ة‬ ‫ا‬ K ? 3Z5 B-.
O15 ‫ل‬ c{١٢
-:
‫أو9%م‬ ‫ل‬ ‫إ‬ 2٢٥
Kk#‫ا‬ 1! ‫اص‬ #‫أ‬٣
- 2 ‫ات‬ -.
‫أو9%م‬ ‫ام‬ . ‫أ‬ R 2
‫ل‬ c{ - 5 ‫اص‬ #‫أ‬
O15٩2‫و‬ ‫ات‬
‫ع‬ #‫أ‬ ‫ام‬ . ‫إ‬
B ‫دو‬ ‫أو‬ B2‫ر‬ 9
- !..
-GU ‫وا‬ ‫ن‬ b‫ا‬ ‫م‬ ‫ا‬"9A 5.5‫أ‬‫اص‬ *
10TAB
Oflam 50
"9A 3.5
‫اص‬ *‫أ‬
10TAB
Oflam25
‫م‬ "% ) ‫ك‬ 9", #!&‫د‬
– Diclofenac
Potassium.
B e 4
٧٥-١٥٠, 56
j 4‫وا‬ K 6‫آ‬ ‫م‬ " ‫ا‬
#K 2C ‫او‬
‫ت‬ K A
K @ ‫ل‬ 0?-‫ا‬)١-
١٢(9%١-٣56
#K 2C ‫م‬ " ‫ا‬ ,
‫ت‬ K A
-‫ن‬ 9%-‫ا‬ $#y
-‫-ت‬ 4 ,
‫ح‬ z)‫وا-ر‬ ‫ب‬ -‫ا‬
‫ت‬ "# ‫ا‬ 5 ~ ‫ا‬
M"4‫ا‬ 6 ‫ا‬
6"9A‫اص‬ *‫أ‬
20TAB
Dolphin K25
mg
8"9A‫اص‬ *‫أ‬
20TAB
Dolphin K50
mg
6.5"9A102'‫آ‬Dolphin K75
mg
6.75"9A3@C4Dolphin K75
mg/3m
٣١| P a g e
B 9‫و‬ ! ‫آ‬
Ketoprofen*M 2'‫آ‬٣‫ات‬
(‫ا-آ‬)٥٠•(
*( K M9C4" &
*MC #٣‫ات‬
١-‫ت‬ ‫د‬
٢-‫-م‬ @!2
٣-‫-ت‬ 4 , K 2
F7-‫ا‬ ‫ت‬ ‫ا‬
‫ة‬ 69I ‫وا‬ ‫وا-ذن‬
‫ن‬ 9%-‫ا‬ ‫ب‬ ‫وا‬
1.75 "9A‫اص‬ *‫أ‬
10TAB
Ketolgin
25mg
2 "9A‫اص‬ *‫أ‬
10TAB
Ketolgin50m
g
8 "9A10 2'‫آ‬Ketolgin
200mg
3 "9A3 @C4Ketolgin100
mg
B 9‫و‬ ! ‫آ‬
Ketoprofen
*M 2'‫آ‬٣‫ات‬
(‫ا-آ‬)٥٠•(
*( K M9C4" &
-GU ‫وا‬ ‫ن‬ b‫ا‬ ‫م‬ ‫ا‬3.753.753.753.75) N‫اص‬ *‫أ‬
10TAB
Ketofan
25mg
5555‫ت‬ ) N20 2'‫آ‬Ketofan
50mg
5555‫ت‬ ) N10 2'‫آ‬Ketofan
75mg
3333‫ت‬ ) N3@C4Ketofan
100mg
G """"""""""" 4‫آ‬ S"""""""""""‫آ‬
‫ى‬ """" 15 G"""" 5% N
6"""""""""::::
200200200200"""""" -
‫اب‬i- B 9‫و‬ ! 42‫ا‬
1- 2@K M 2'‫آ‬
( ‫آ‬ 5 0 ‫ا‬ S & ?٤-
٦9K ‫أو‬ ‫ت‬ K %
‫وم‬Z# ‫ا‬.
@! 2 @" 0" ‫را‬
‫€-م‬ $& %
‫ل‬ , R, y‫و‬
‫د‬ ‫و‬ ‫ارة‬ I#
‫ت‬ -
3.503.503.503.50) N‫اص‬ *‫أ‬
10TAB
Rapifen200
mg
٣٢| P a g e
1-paracetamol
350mg
2-ibuprofen
200mg
B e 4
‫ات‬ - ‫3%ث‬ ‫ص‬ #
- 2
‫ل‬ c%
‫"%ث‬""3 ‫ص‬ """# Q"""k$
- 2 ‫ات‬ -
GU ‫وا‬ ‫ن‬ b‫ا‬ ‫م‬ ‫ا‬2.752.752.752.75) N‫اص‬ *‫أ‬
20TAB
Megafen
ibuprofen-1‫ر‬ """""""""4L:S"""""""""+ 2
""""" ! ?i"""""w‫ا‬‫م‬ """"" , ‫ا‬
6"""" ?‫ر‬ """"3‫ا‬ S""""
G""""""" N‫و‬ ? """"""" ‫ا‬
‫ر‬ """""4L٤٠٠""""" -
‫ت‬ O S‫آ‬
‫ل‬ c%:S+ 2
K‫وه‬ # G N
٢٠٠O S‫آ‬ -
‫ت‬
‫3""""""""%ث‬ ‫اب‬ """"""""€ ‫او‬
- 2 ‫ات‬ -
GU ‫وا‬ ‫ن‬ b‫ا‬ ‫م‬ ‫ا‬
B L ‫ا‬ Sk - ‫م‬ ‫ا‬
6.756.756.756.75) N‫اص‬ *‫أ‬
20TAB
Brufen200
mg
13.5013.5013.5013.50) N‫اص‬ *‫أ‬
20TAB
Brufen400
mg
15151515) N‫اص‬ *‫أ‬
20TAB
Brufen600
mg
6666) N‫اب‬ rBrufen100
mg /150ml
٣٣| P a g e
‫ك‬ 9 L2‫د‬
‫م‬ 2‫د‬ ]
‫ر‬ """""""4L ‫ا‬:٧٥-١٥٠
‫م‬ " ‫ا‬ P , 5 c#،
‫او‬ ‫ة‬ 4‫وا‬ M K 6
M K‫ز‬ ‫و‬ M 2C
‫م‬ " ‫ا‬ ‫ل‬ y.
‫ل‬ c ‫ا‬:٣(! •#
S& ? @K ‫م‬ " ‫ا‬ P, 56‫آ‬
#K M 2C 50 ‫ا‬٢-٤
ً" & ‫ات‬.
‫ل‬ `:(0/ ‫ا‬ ‫وزن‬ ‫ن‬ ‫آ‬ ‫إذا‬
٣٠/ & 56‫آ‬٦٠‫إ‬
٩٠#K M 2C •#٢-
٤P & ‫ات‬
-‫ل‬ o‫ا‬ 6 ‫دوا‬
-‫ن‬ b‫ا‬ ‫م‬ ‫ا‬
GU ‫وا‬.
11.2511.2511.2511.25) N‫اص‬ *‫أ‬
30TAB
Voltaren 25
11.9011.9011.9011.90) N‫اص‬ *‫أ‬
20TAB
Voltaren 50
28) N‫اص‬ *‫أ‬
10sr TAB
Voltaren-
sr 100
12.75) N3@C4Voltaren 75
Ibuprofen‫ر‬ """4L ‫ا‬:‫واء‬ ‫ا‬ s y‫أ‬
M &‫و‬ y ‫ة‬ P #K
( ,‫أ‬ P / &
‫إن‬ ‫و‬ ‫ص‬ = ‫أ‬
( 0 ‫ا‬ @ ‫ن‬ ‫آ‬
‫م‬ / ‫ا‬ $ js y‫أ‬
‫ر‬ ‫ا‬ j "+d ) ( "#C
‫ة‬ ‫ا‬ P#K.
P / &٤٠٠5 6
D % ‫أو‬ $ ‫أر‬ ( ‫آ‬
‫ت‬ K %.
‫ا‬s ‫ه‬ ‫َم‬ 2ُ&
‫ج‬ ُ‫ء‬‫…وا‬ ‫ا‬
‫ب‬ ‫ا‬( ِm 0 ‫ا‬
B """""""L ‫ا‬ S"""""""k ‫آ‬
""""""" ‫ا‬ Q""""""" . ‫و‬
S] ‫ا‬ K9.
4) N‫اص‬ *‫أ‬
10sr TAB
Ibuprofen
400mg Tabs
٣٤| P a g e
Mefenamic acid٥٠٠‫ام‬ N S-٣
- 2 ‫ات‬ -.
*T4 = ‫ا‬ 5 v‫ا‬
‫ب‬ -‫ا‬ ‫أو‬ ‫رم‬ #
‫ت‬ m|‫ا‬ $ ' & ‫ي‬s ‫ا‬
‫أو‬ M" ‫ا‬
M"4‫ا‬ 6 ‫ا‬.
‫ت‬ ‫إ‬0 ‫ا‬(m
-*‫ارة‬ I# R, y.
5.50) N‫اص‬ *‫أ‬
10 TAB
Mefenam
500mg
Lornicam*@ ‫ص‬ * $ #'&
‫م‬ !"7‫ر‬٨5 6
M & % ‫اص‬ *‫ا‬
" ‫آ‬ $ @ ‫و‬s ‫ا‬
@ ' % 9
(_‫ا‬ 2 ‫ا‬.
*‫ول‬ 9) 5 &
, ‫اص‬ *-‫ا‬
‫ت‬ K A@
٨T 6& -‫و‬ 5 6
I ‫ا‬ / )
‫ح‬ 2 ‫ا‬ =*-‫ا‬
‫ت‬ K 6 ‫ا‬ @
‫وه‬١٦" & 56
p') ‫ا‬ 5 -‫ا‬
‫ب‬‫رج‬ y
( m 0 ‫ا‬‫ج‬ ‫و‬
5 -‫ا‬ ‫اض‬ K‫ا‬
, ‫ب‬ -‫وا‬
‫ب‬ -‫ا‬ ‫-ت‬ 4
Y ‫ا‬
‫ب‬ ‫وا‬ # =0 ‫ا‬
( =0 ‫ا‬
7‫ا‬ + ‫ا‬.
13.00) N‫اص‬ *‫أ‬
10 TAB
Lornicam
Rapid
tablets
٣٥| P a g e
oral
gel
Daktarin
oral
gel
Miconaz 2%
oral
gel
Micoban 2%
- 2 ‫ات‬ - ‫3%ث‬*‫"""""""""""""""""%ج‬
‫ا‬ ‫ت‬ 2 ,9
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ا‬ 2 $ ‫آ‬
18‫ت‬ "9A
- 2 ‫ات‬ - ‫3%ث‬
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ت‬ 2 ,9
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ا‬ 2 $ ‫آ‬
4,70‫ت‬ "9A
- 2 ‫ات‬ - ‫3%ث‬
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ت‬ 2 ,9
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ا‬ 2 $ ‫آ‬
4,90‫ت‬ "9A
٣٦| P a g e
Miconazole
nitrate- 2 ‫ات‬ - ‫3%ث‬
Miconazole
nitrate- 2 ‫ات‬ - ‫3%ث‬
Miconazole
nitrate- 2 ‫ات‬ - ‫3%ث‬
٣٧| P a g e
Nystatin
mechanism
NYSTATIN
bind to sterols in
the fungal cell
membrane...
RESULTING
IN disturbances
in cell
membrane
function as
selective barrier
,THIS LEADS
TO loss of
essential cellular
constituents
- 2 ‫ات‬ - ‫3%ث‬
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ت‬ 2 ,9
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ا‬ 2 $ ‫آ‬
3.50"9AOral
drops
Nystatin 30 ml
Nystatin
S 2 ‫ا‬ ‫م‬Z7 !" ‫ا‬ U07
.‫آ‬٨‫ت‬ 0/٦
& ‫ا‬ 3$4 ‫ت‬ 0
$ ‫ا‬ ‫او‬
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ت‬ 2 ,9
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ا‬ 2 $ ‫آ‬
4‫ت‬ "9AOral
drops
Fungistatin
30ml
Nystatin
r $‫م‬p$ L ‫ا‬
m! ‫ا‬
.‫آ‬٨‫ت‬ 0/٦
& ‫ا‬ 3$4 ‫ت‬ 0
$ ‫ا‬ ‫او‬
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ت‬ 2 ,9
*‫"""""""""""""""""%ج‬
‫ا‬ ‫ا‬ 2 $ ‫آ‬
4‫ت‬ "9AOral
drops
MYCOSTATI
N 30 ml
٣٨| P a g e
٣٩| P a g e
Calcium
glubionate
1200mg5ml
- 2 ? ‫وا‬ ? -•"""""""""""""""""""""" $
‫م‬ L ‫ا‬
‫ى‬i"" ‫ا‬ ‫ل‬ "" c ‫ا‬
6"""""" ‫ا‬ ‫دى‬ """"""2
‫ر‬ """") w """"5
‫ن‬ ‫ا‬
5‫ت‬ "9A
‫اب‬ rHi-cal 100ml
Calcium- 2 ? ‫وا‬ ? -•"""""""""""""""""""""" $
‫م‬ L ‫ا‬
‫ى‬i"" ‫ا‬ ‫ل‬ "" c ‫ا‬
6"""""" ‫ا‬ ‫دى‬ """"""2
‫ر‬ """") w """"5
‫ن‬ ‫ا‬
5‫ت‬ "9A
‫اب‬ rGolden cal
100ml
Calcium" & j 4‫وا‬ j•"""""""""""""""""""""" $
‫م‬ L ‫ا‬
‫ى‬i"" ‫ا‬ ‫ل‬ "" c ‫ا‬
6"""""" ‫ا‬ ‫دى‬ """"""2
‫ر‬ """") w """"5
‫ن‬ ‫ا‬
7.50‫ت‬ "9A‫اب‬ rCalci cal
٤٠| P a g e
Calcium
carbonate
500mg
Adult 500mg
1-2times after
meals
Children 250-
500mg daily
•"""""""""""""""""""""" $
‫م‬ """""""""""" L ‫ا‬
""""" ‫ا‬ ‫ء‬ """"" 3‫ا‬
-? """""""""
B2 """"""L5 6""""""9
‫ن‬ ‫ا‬2 #
3‫ت‬ "9A12 cap
- 2'‫آ‬
‫ت‬
Calcimate 500
500mg of
calcium
Adult 500mg
1-2times after
meals
Children 250-
500mg daily
•"""""""""""""""""""""" $
‫م‬ """""""""""" L ‫ا‬
""""" ‫ا‬ ‫ء‬ """"" 3‫ا‬
-? """""""""
B2 """"""L5 6""""""9
2 # ‫ن‬ ‫ا‬
6‫ت‬ "9A‫اص‬ *‫أ‬
10
TAB
Bone-cal
*Calcium
carbonate
=700mg
*calcium 180mg
Adult 500mg
1-2times after
meals
Children 250-
500mg daily
•"""""""""""""""""""""" $
‫م‬ """""""""""" L ‫ا‬
""""" ‫ا‬ ‫ء‬ """"" 3‫ا‬
-? """""""""
B2 """"""L5 6""""""9
2 # ‫ن‬ ‫ا‬
15‫ت‬ "9A‫اص‬ *‫أ‬
30
TAB
marcal
٤١| P a g e
٤٢| P a g e
Cod liver oil
‫ت‬ I ‫ا‬ '‫آ‬ D&
1cap _ 1-2times
daily
_‫ا‬s g ( !
‫ر‬ = ' &
‫د‬ @" "0
@" ",»‫د‬«
#K K 2&
T" % )
=9K
P , ‫م‬ " 2 ! ‫ا‬
‫م‬ Y ‫ا‬
‫ن‬ 9%v‫وا‬
22‫ت‬ "9A- 2'‫آ‬
‫ت‬
120
cap
Seven seas
Cod liver oil
+vit a.d3.c
1 cap _ 1-
2times daily
U 07
0"‰ ‫ا‬
C 2 ‫ا‬
29‫ت‬ "9A- 2'‫آ‬
‫ت‬
20 cap
Ultranyl
Cod liver oilAdult 1 cap _
1-2times daily
U 07
0"‰ ‫ا‬
C 2 ‫ا‬
28‫ت‬ "9A- 2'‫آ‬
‫ت‬
20 capCod liver oil
٤٣| P a g e
Cod liver oil
100mg
Adult 1cap _ 1-
2times daily
_‫ا‬s g ( !
‫ر‬ = ' &
‫د‬ @" "0
@" ",»‫د‬«
#K K 2&
T" % )
=9K
P , ‫م‬ " 2 ! ‫ا‬
‫م‬ Y ‫ا‬
‫ن‬ 9%v‫وا‬
14,90‫ت‬ "9A- 2'‫آ‬
‫ت‬
20 cap
Fort sea
vitA,c,d,omega
3,EPA.DHA
2.5:5ml.2-3
times daily
according to
kids edge
0"‰ ‫ا‬ U 07
C 2 ‫ا‬
14,90‫ت‬ "9A120ml.
‫اب‬ r
High sea 120ml
Vit.A4600i.u
Vit D380i.u
C52mg
2.5:5ml.2-3
times daily
according to
kids edge
0"‰ ‫ا‬ U 07
C 2 ‫ا‬
13,90‫ت‬ "9A120ml
‫اب‬ r
Halorang 120ml
٤٤| P a g e
٤٥| P a g e
Lidocaine hcl
40mg
MK 6:
‫"%ج‬"""""""""" 6"""""""""""9
‫ن‬ """"""""""" ‫ا‬١-٥
6""""""""" ‫ت‬ """"""""".!
G """""""""""""""""""""""dw ‫ا‬
G"""""""""""""""" c . ‫ا‬-
3 """"""" ‫ا‬ ‫اء‬ """""""42
‫"%ل‬"""""""""""""""""w١-٢
G #‫د‬
‫ر‬ ‫آ‬
( '*
‫زرع‬ ‫او‬ @ CI ‫ا‬
( '* ‫او‬ ‫ن‬ 9 %-‫ا‬
@ Š# ‫ا‬
‫او‬ "6 ‫ا‬
‫ر‬ ‫آ‬
,
‫ل‬s ‫ا‬ "# K
!0 ‫ا‬ T"6#
8‫ت‬ "9ASPRA
Y
‫خ‬
LIDO SPRAY
Lidocaine 10%MK 6:
6"""""""""""9‫"%ج‬""""""""""
‫ن‬ """"""""""" ‫ا‬١-٥
6""""""""" ‫ت‬ """"""""".!
G """""""""""""""""""""""dw ‫ا‬
G"""""""""""""""" c . ‫ا‬-
3 """"""" ‫ا‬ ‫اء‬ """""""42
‫"%ل‬"""""""""""""""""w١-٢
G #‫د‬
‫ر‬ ‫آ‬
( '*
‫زرع‬ ‫او‬ @ CI ‫ا‬
( '* ‫او‬ ‫ن‬ 9 %-‫ا‬
@ Š# ‫ا‬
‫او‬ "6 ‫ا‬
‫ر‬ ‫آ‬
,
‫ل‬s ‫ا‬ "# K
!0 ‫ا‬ T"6#
١٠‫ت‬ "9ASPRA
Y
‫خ‬
Lidocaine
SPRAY
Lidocaine 5%MK A:
‫"%ج‬"""""""""" 6"""""""""""9
‫ن‬ """"""""""" ‫ا‬١-٥
6""""""""" ‫ت‬ """"""""".!
G """""""""""""""""""""""dw ‫ا‬
G"""""""""""""""" c . ‫ا‬-
3 """"""" ‫ا‬ ‫اء‬ """""""42
‫"%ل‬"""""""""""""""""w١-٢
G #‫د‬
‫ر‬ ‫آ‬
( '*
‫زرع‬ ‫او‬ @ CI ‫ا‬
( '* ‫او‬ ‫ن‬ 9 %-‫ا‬
@ Š# ‫ا‬
‫او‬ "6 ‫ا‬
‫ر‬ ‫آ‬
,
‫ل‬s ‫ا‬ "# K
!0 ‫ا‬ T"6#
2.40‫ت‬ "9A5‫ه‬LIDOSINE
٤٦| P a g e
Lidocaine 2%MK A:
‫"%ج‬""""""""" 6""""""""""9
‫ن‬ """"""""""" ‫ا‬١-٥
6""""""""" ‫ت‬ """"""""".!
G """""""""""""""""""""""dw ‫ا‬
G"""""""""""""""" c . ‫ا‬-
3 """"""" ‫ا‬ ‫اء‬ """""""42
‫"%ل‬"""""""""""""""""w١-٢
G #‫د‬
S 2 ‫ا‬ U073‫ت‬ "9AGelLIGNOCAINE
Lidocaine 10%MK A:
‫"%ج‬""""""""" 6""""""""""9
‫ن‬ """"""""""" ‫ا‬١-٥
6""""""""" ‫ت‬ """"""""".!
G """""""""""""""""""""""dw ‫ا‬
G"""""""""""""""" c . ‫ا‬-
3 """"""" ‫ا‬ ‫اء‬ """""""42
‫"%ل‬"""""""""""""""""w١-٢
G #‫د‬
‫ر‬ ‫آ‬
( '*
‫زرع‬ ‫او‬ @ CI ‫ا‬
‫ن‬ 9 %-‫ا‬( '* ‫او‬
@ Š# ‫ا‬
‫او‬ "6 ‫ا‬
‫ر‬ ‫آ‬
,
‫ل‬s ‫ا‬ "# K
!0 ‫ا‬ T"6#
10‫ت‬ "9ASPRA
Y
‫خ‬
LIGNOCAINE
٤٧| P a g e
Lidocaine 10%MK A:
‫"%ج‬""""""""" 6""""""""""9
‫ن‬ """"""""""" ‫ا‬١-٥
6""""""""" ‫ت‬ """"""""".!
G """""""""""""""""""""""dw ‫ا‬
G"""""""""""""""" c . ‫ا‬-
3 """"""" ‫ا‬ ‫اء‬ """""""42
‫"%ل‬"""""""""""""""""w١-٢
G #‫د‬
‫ر‬ ‫آ‬
( '*
‫زرع‬ ‫او‬ @ CI ‫ا‬
( '* ‫او‬ ‫ن‬ 9 %-‫ا‬
Š# ‫ا‬@
‫او‬ "6 ‫ا‬
‫ر‬ ‫آ‬
,
‫ل‬s ‫ا‬ "# K
!0 ‫ا‬ T"6#
10‫ت‬ "9ASPRA
Y
‫خ‬
LIGNORAL
Lidocaine 10%MK A:
‫"%ج‬""""""""" 6""""""""""9
‫ن‬ """"""""""" ‫ا‬١-٥
6""""""""" ‫ت‬ """"""""".!
G """""""""""""""""""""""dw ‫ا‬
G"""""""""""""""" c . ‫ا‬-
3 """"""" ‫ا‬ ‫اء‬ """""""42
‫"%ل‬"""""""""""""""""w١-٢
G #‫د‬
‫ر‬ ‫آ‬
( '*
‫زرع‬ ‫او‬ @ CI ‫ا‬
( '* ‫او‬ ‫ن‬ 9 %-‫ا‬
@ Š# ‫ا‬
‫او‬ "6 ‫ا‬
‫ر‬ ‫آ‬
,
‫ل‬s ‫ا‬ "# K
!0 ‫ا‬ T"6#
44.75‫ت‬ "9ASPRA
Y
‫خ‬
Xylocaine
٤٨| P a g e
٤٩| P a g e
Hydrocortisone
‫ات‬ &‫و‬ 2 ‫ا‬ @ ‫ه‬
( & ‫وه‬ & zC ‫ا‬
$9 ‫او‬ R0y #K
6 %-‫ا‬ @ & ‫ا‬
S& ? @K ‫ت‬
‫ز‬ 6 ‫ا‬ , "c ‫ا‬
K 9 ‫ا‬
" & @"), !I ‫ا‬
@" 0 z
" &Z‫وا-آ‬
‫او‬ 0 z ‫ا‬ ,
'7 A
5.50‫ت‬ "9A5& ‫آ‬
10gm
Hydrocortisone
1%
1-Lidocaine
‫ر‬
2-aminacrine
A highly
fluorescent anti-
infective dye used
clinically as a
topical antiseptic
and experimentally
as a mutagen,
3-ethanol
‫ة‬ / ‫دة‬ ‫آ‬ ‫م‬ 2&
M"
4-sucrose
, - & !% j‫د‬
#4 5 ?
5-saccrine
, - & !% j‫د‬
#4 5 ?
" & @")‫ن‬ 9 %-‫ا‬ 5 ‫ا‬
@"9 2 ‫ا‬ ‫ء‬ 9+‫ا‬
7‫ت‬ "9AGelDentinox
teething gel
Acyclovir
M"%‫و‬ "0 ‫ا‬ ‫دات‬ ‫ا‬ `‫أآ‬
(!z ‫م‬ 2& ،ًK "r
‫وى‬ K ‫ج‬ ‫ص‬ y
p"2' ‫ا‬ U ‫ا‬ ‫وس‬ ",
" & ‫ات‬ $ ‫ار‬‫ج‬ ‫م‬ 2&
‫وي‬ K
P ‫ا‬ U " ‫ا‬
#6 ‫ا‬ T" =)،
5 0 ‫ا‬،M" zg|‫ا‬
M"? ‫ا‬
4.5"9ACreamAcyclovir 5%
٥٠| P a g e
Acyclovir
‫دات‬ ‫ا‬ `‫أآ‬
M"%‫و‬ "0 ‫ا‬ ،ًK "r
‫ص‬ y (!z ‫م‬ 2&
‫وس‬ ", ‫وى‬ K ‫ج‬
p"2' ‫ا‬ U ‫ا‬
" & ‫ات‬ $ ‫ار‬‫ج‬ ‫م‬ 2&
‫وي‬ K
P ‫ا‬ U " ‫ا‬
#6 ‫ا‬ T" =)،
5 0 ‫ا‬،M" zg|‫ا‬
M"? ‫ا‬
12.5"9A‫ت‬Creamzovirax 5%
Chlorzoxaze
‫زون‬ 2‫رزوآ‬ #! ‫ا‬
Chlorzoxazone
‫ت‬ "ِy ُ @ ‫ه‬
(!" ‫وا‬ ‫ت‬ ‫ا‬
(َ َ) P ‫ا‬ P Y ‫ا‬
ً&Z‫آ‬ centrally
acting skeletal
muscle relaxants.
Paracetamol
‫ل‬ 6 ‫ا‬ $ %‫وا‬ @! 2
j‫ار‬ I# R, y‫و‬،
" & ‫ات‬ ‫ث‬ +p %
, ‫ت‬ #
z ‫ا‬ 4
Y ‫ا‬
o0 ‫ا‬ ‫ت‬
12"9A‫ت‬20
‫ت‬ 4‫آ‬
Myolgin
PEPPERMIN
T
OIL+EUCAL
YPTUS
OIL+THYME
EXT.
" & ‫ات‬ ‫ث‬ +z ‫ا‬ ‫-ت‬ I
, # ‫ا‬
‫ت‬ K
@"!0 ‫ا‬
24"9A5& ‫آ‬Relax
massage
cream
٥١| P a g e

More Related Content

What's hot

Facemask/Reverse pull headgear
Facemask/Reverse pull headgearFacemask/Reverse pull headgear
Facemask/Reverse pull headgear
M Shariq Sohail
 
Dental Management of Asthmatic Patient Lecture
Dental Management of Asthmatic Patient LectureDental Management of Asthmatic Patient Lecture
Dental Management of Asthmatic Patient Lecture
Iraqi Dental Academy
 
Mouth breathing
Mouth breathingMouth breathing
Mouth breathing
Nursing Hi Nursing
 
Relation of oral health, general health and NCDs (Christoph Benz)
Relation of oral health, general health and NCDs (Christoph Benz)Relation of oral health, general health and NCDs (Christoph Benz)
Relation of oral health, general health and NCDs (Christoph Benz)
fdiworlddental
 
dental management of a renal disorder patient
dental management of a renal disorder patientdental management of a renal disorder patient
dental management of a renal disorder patient
Sumaira Saeed
 
Disturbances of growth of (Eruption) of teeth
Disturbances of growth of (Eruption) of teethDisturbances of growth of (Eruption) of teeth
Disturbances of growth of (Eruption) of teeth
Indian dental academy
 
Tooth wear and its types
Tooth wear and its typesTooth wear and its types
Tooth wear and its typesaneeqa_yaqub
 
young permanent tooth
young permanent toothyoung permanent tooth
young permanent toothJeena Paul
 
Analgesics used in Dental Practice
Analgesics used in Dental PracticeAnalgesics used in Dental Practice
Analgesics used in Dental Practice
Iraqi Dental Academy
 
space-maintainers-pedo
space-maintainers-pedospace-maintainers-pedo
space-maintainers-pedoParth Thakkar
 
07.non carious lesions
07.non carious lesions07.non carious lesions
07.non carious lesions
Dr.Jaffar Raza BDS
 
MANAGEMENT OF BRUXISM, LIP BITING AND MASOCHISTIC HABITS
MANAGEMENT OF BRUXISM, LIP BITING AND MASOCHISTIC HABITSMANAGEMENT OF BRUXISM, LIP BITING AND MASOCHISTIC HABITS
MANAGEMENT OF BRUXISM, LIP BITING AND MASOCHISTIC HABITS
aanchalshruti
 
ORTHODONTIC INSTRUMENTS
ORTHODONTIC INSTRUMENTSORTHODONTIC INSTRUMENTS
ORTHODONTIC INSTRUMENTS
SURGICOSE
 
Antiseptics used in dentistry
Antiseptics used in dentistryAntiseptics used in dentistry
Antiseptics used in dentistry
Kyaw Htoo Lwin
 
Epidemiology of periodontal diseases
Epidemiology of periodontal diseasesEpidemiology of periodontal diseases
Epidemiology of periodontal diseases
Dr sakshi kaur chhabra
 
Apexification Procedure - Pediatric Dental Lecture
Apexification Procedure - Pediatric Dental LectureApexification Procedure - Pediatric Dental Lecture
Apexification Procedure - Pediatric Dental Lecture
Iraqi Dental Academy
 
The Smear layer in endodontics
The Smear layer in endodonticsThe Smear layer in endodontics
The Smear layer in endodontics
Dr. Arpit Viradiya
 

What's hot (20)

Facemask/Reverse pull headgear
Facemask/Reverse pull headgearFacemask/Reverse pull headgear
Facemask/Reverse pull headgear
 
Dental Management of Asthmatic Patient Lecture
Dental Management of Asthmatic Patient LectureDental Management of Asthmatic Patient Lecture
Dental Management of Asthmatic Patient Lecture
 
Brushing techniques
Brushing techniquesBrushing techniques
Brushing techniques
 
Mouth breathing
Mouth breathingMouth breathing
Mouth breathing
 
wedges
wedgeswedges
wedges
 
Relation of oral health, general health and NCDs (Christoph Benz)
Relation of oral health, general health and NCDs (Christoph Benz)Relation of oral health, general health and NCDs (Christoph Benz)
Relation of oral health, general health and NCDs (Christoph Benz)
 
dental management of a renal disorder patient
dental management of a renal disorder patientdental management of a renal disorder patient
dental management of a renal disorder patient
 
Disturbances of growth of (Eruption) of teeth
Disturbances of growth of (Eruption) of teethDisturbances of growth of (Eruption) of teeth
Disturbances of growth of (Eruption) of teeth
 
Tooth wear and its types
Tooth wear and its typesTooth wear and its types
Tooth wear and its types
 
young permanent tooth
young permanent toothyoung permanent tooth
young permanent tooth
 
Analgesics used in Dental Practice
Analgesics used in Dental PracticeAnalgesics used in Dental Practice
Analgesics used in Dental Practice
 
Fixed prosthodontics lesson 7
Fixed prosthodontics lesson 7Fixed prosthodontics lesson 7
Fixed prosthodontics lesson 7
 
space-maintainers-pedo
space-maintainers-pedospace-maintainers-pedo
space-maintainers-pedo
 
07.non carious lesions
07.non carious lesions07.non carious lesions
07.non carious lesions
 
MANAGEMENT OF BRUXISM, LIP BITING AND MASOCHISTIC HABITS
MANAGEMENT OF BRUXISM, LIP BITING AND MASOCHISTIC HABITSMANAGEMENT OF BRUXISM, LIP BITING AND MASOCHISTIC HABITS
MANAGEMENT OF BRUXISM, LIP BITING AND MASOCHISTIC HABITS
 
ORTHODONTIC INSTRUMENTS
ORTHODONTIC INSTRUMENTSORTHODONTIC INSTRUMENTS
ORTHODONTIC INSTRUMENTS
 
Antiseptics used in dentistry
Antiseptics used in dentistryAntiseptics used in dentistry
Antiseptics used in dentistry
 
Epidemiology of periodontal diseases
Epidemiology of periodontal diseasesEpidemiology of periodontal diseases
Epidemiology of periodontal diseases
 
Apexification Procedure - Pediatric Dental Lecture
Apexification Procedure - Pediatric Dental LectureApexification Procedure - Pediatric Dental Lecture
Apexification Procedure - Pediatric Dental Lecture
 
The Smear layer in endodontics
The Smear layer in endodonticsThe Smear layer in endodontics
The Smear layer in endodontics
 

Viewers also liked

Implantology for gp - زرع الأسنان لطبيب الاسنان العام
Implantology for gp - زرع الأسنان لطبيب الاسنان العامImplantology for gp - زرع الأسنان لطبيب الاسنان العام
Implantology for gp - زرع الأسنان لطبيب الاسنان العام
DenTeach
 
Dental infection control post treatment last
Dental infection control post treatment lastDental infection control post treatment last
Dental infection control post treatment lastAmin Abusallamah
 
10 infection control
10 infection control10 infection control
10 infection control
Vasundhara naik
 
Sterilization and disinfection
Sterilization and disinfectionSterilization and disinfection
Sterilization and disinfection
Sushant Kumar
 
Antibiotics in dentistry
Antibiotics in dentistryAntibiotics in dentistry
Antibiotics in dentistry
Chia Kadir
 
Antibiotics & analgesics dentistry
Antibiotics  & analgesics dentistryAntibiotics  & analgesics dentistry
Antibiotics & analgesics dentistry
Hema Latha
 
Ergonomics in dentistry
Ergonomics in dentistryErgonomics in dentistry
Ergonomics in dentistry
Rakesh Nair
 

Viewers also liked (9)

Implantology for gp - زرع الأسنان لطبيب الاسنان العام
Implantology for gp - زرع الأسنان لطبيب الاسنان العامImplantology for gp - زرع الأسنان لطبيب الاسنان العام
Implantology for gp - زرع الأسنان لطبيب الاسنان العام
 
Dental infection control post treatment last
Dental infection control post treatment lastDental infection control post treatment last
Dental infection control post treatment last
 
10 infection control
10 infection control10 infection control
10 infection control
 
endodontics
endodonticsendodontics
endodontics
 
Sterilization and disinfection
Sterilization and disinfectionSterilization and disinfection
Sterilization and disinfection
 
Antibiotics in dentistry
Antibiotics in dentistryAntibiotics in dentistry
Antibiotics in dentistry
 
drugs used in dentistry
drugs used in dentistrydrugs used in dentistry
drugs used in dentistry
 
Antibiotics & analgesics dentistry
Antibiotics  & analgesics dentistryAntibiotics  & analgesics dentistry
Antibiotics & analgesics dentistry
 
Ergonomics in dentistry
Ergonomics in dentistryErgonomics in dentistry
Ergonomics in dentistry
 

More from DenTeach

Zirconia crown preparation
Zirconia crown preparationZirconia crown preparation
Zirconia crown preparation
DenTeach
 
Stem cells in Dentistry | by Dr Alaa Al-saidi
Stem cells in Dentistry | by Dr Alaa Al-saidiStem cells in Dentistry | by Dr Alaa Al-saidi
Stem cells in Dentistry | by Dr Alaa Al-saidi
DenTeach
 
Tooth hypersensitivity | by: Dr Muneera Ghaithan
Tooth hypersensitivity | by: Dr Muneera GhaithanTooth hypersensitivity | by: Dr Muneera Ghaithan
Tooth hypersensitivity | by: Dr Muneera Ghaithan
DenTeach
 
Impacted teeth | by Dr.Basma Elbeshlawy
Impacted teeth | by Dr.Basma ElbeshlawyImpacted teeth | by Dr.Basma Elbeshlawy
Impacted teeth | by Dr.Basma Elbeshlawy
DenTeach
 
Dental common disease on x-ray | by Dr.mohammad nameer
Dental common disease on x-ray | by Dr.mohammad nameerDental common disease on x-ray | by Dr.mohammad nameer
Dental common disease on x-ray | by Dr.mohammad nameer
DenTeach
 
Extraction instruments | Dental surgery | by Dr.mohammad nameer
Extraction instruments | Dental surgery | by Dr.mohammad nameerExtraction instruments | Dental surgery | by Dr.mohammad nameer
Extraction instruments | Dental surgery | by Dr.mohammad nameer
DenTeach
 
Classification of impression materials انواع مواد الطبع
Classification of impression materials  انواع مواد الطبعClassification of impression materials  انواع مواد الطبع
Classification of impression materials انواع مواد الطبع
DenTeach
 
Instrumentation En macro-chirurgie by oussama khelif
Instrumentation  En macro-chirurgie by oussama khelifInstrumentation  En macro-chirurgie by oussama khelif
Instrumentation En macro-chirurgie by oussama khelif
DenTeach
 

More from DenTeach (8)

Zirconia crown preparation
Zirconia crown preparationZirconia crown preparation
Zirconia crown preparation
 
Stem cells in Dentistry | by Dr Alaa Al-saidi
Stem cells in Dentistry | by Dr Alaa Al-saidiStem cells in Dentistry | by Dr Alaa Al-saidi
Stem cells in Dentistry | by Dr Alaa Al-saidi
 
Tooth hypersensitivity | by: Dr Muneera Ghaithan
Tooth hypersensitivity | by: Dr Muneera GhaithanTooth hypersensitivity | by: Dr Muneera Ghaithan
Tooth hypersensitivity | by: Dr Muneera Ghaithan
 
Impacted teeth | by Dr.Basma Elbeshlawy
Impacted teeth | by Dr.Basma ElbeshlawyImpacted teeth | by Dr.Basma Elbeshlawy
Impacted teeth | by Dr.Basma Elbeshlawy
 
Dental common disease on x-ray | by Dr.mohammad nameer
Dental common disease on x-ray | by Dr.mohammad nameerDental common disease on x-ray | by Dr.mohammad nameer
Dental common disease on x-ray | by Dr.mohammad nameer
 
Extraction instruments | Dental surgery | by Dr.mohammad nameer
Extraction instruments | Dental surgery | by Dr.mohammad nameerExtraction instruments | Dental surgery | by Dr.mohammad nameer
Extraction instruments | Dental surgery | by Dr.mohammad nameer
 
Classification of impression materials انواع مواد الطبع
Classification of impression materials  انواع مواد الطبعClassification of impression materials  انواع مواد الطبع
Classification of impression materials انواع مواد الطبع
 
Instrumentation En macro-chirurgie by oussama khelif
Instrumentation  En macro-chirurgie by oussama khelifInstrumentation  En macro-chirurgie by oussama khelif
Instrumentation En macro-chirurgie by oussama khelif
 

Recently uploaded

Chapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdfChapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdf
Kartik Tiwari
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
Mohammed Sikander
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
chanes7
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 

Recently uploaded (20)

Chapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdfChapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdf
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 

كتاب ادوية طب الاسنان اعداد د. عبد الله نصر

  • 1. ٠| P a g e
  • 2. ١| P a g e
  • 3. ٢| P a g e
  • 4. ٣| P a g e ‫آ‬ ‫ا‬‫ا‬ ‫ا‬ ‫ا‬‫ا‬‫ع‬ ‫ا‬‫واء‬ ‫رى‬ ‫ا‬ ‫ا‬ benzocaine-1 )‫ر‬( benzydamine-2 hydrochl ‫ب‬ ‫د‬ cetalkonium-3 ‫ان‬ ‫آ‬ ‫ت‬ ‫و‬ !" # ‫د‬ $ %‫وا‬ & !'# ( ) * "+ ) ‫ا‬ , - ‫ى‬ ‫ا‬ ‫ت‬ & /0# ‫د‬ ‫آ‬ ‫ا‬ %‫ا‬ ‫م‬ 2& ‫ث‬ + 4 ‫ات‬ " & / ‫ر‬ ‫و‬ 5 0 ‫ا‬ 6 27- –‫و‬ ( '* ‫ت‬ "# ‫ا‬ "4‫ا‬ 6 ‫ا‬ $ 9 ‫ب‬ -‫ا‬. *< =9& - ‫ل‬ 0? @2 ‫ا‬ ‫ر‬ '‫آ‬ ‫او‬ 9.5 ‫ت‬ "9A ‫خ‬ spray B.B.C benzocaine-1 )‫ر‬( clove oil-2 ( 07 C ‫ا‬ D &‫ز‬–/ 5 F0 ‫وح‬ # @") " & @! 2 5 - ‫ر‬ ‫و‬ ‫ن‬ 9%-‫ا‬ 1.5 ‫ت‬ "9A 5‫ه‬Dentocalm clove oil-1 (07 C ‫ا‬ D&‫ز‬–‫وح‬ # / 5 F0 geranium-2 " ‫ا‬ & ‫ا‬ & 6) lidocaine-3 )‫ر‬( @") " & 5 - @!2 ‫ن‬ 9%-‫ا‬ 3.50 ‫ت‬ "9A #I‫ل‬Clovacaine
  • 5. ٤| P a g e benzocaine-1 )‫ر‬( ( ‫آ‬١٢ K % (‫ا-آ‬ ‫ن‬ 9% ‫ر‬2‫ت‬ "9A5‫ه‬Dentocaine Jojoba oil-1 ( ) * ‫و‬ ‫ت‬ ‫د‬ ‫ع‬ 2& ‫و‬ & !' ‫ا‬ @ ‫اع‬ 7- M, - ‫وح‬ 6 ‫ا‬ ‫م‬ N ‫إ‬ P , F/# 7‫أ‬ P ‫إ‬ lidocaine-2 )‫ر‬( @") " & ‫ر‬ ‫و‬ / 5 0 ‫ا‬ 6 27-– ‫ج‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫آ‬ ‫ا‬ ‫ا‬ 5 ‫ت‬ "9A gelJogel aminacrine-1 (used as a topical antiseptic) lidocaine-2 )‫ر‬( @") " & 50# / ‫ر‬ ‫و‬ 7‫ت‬ "9AgelMedijel cetalkonium-1 ‫ان‬ ‫آ‬ ‫ت‬ ‫و‬ !" # ‫د‬ ‫ى‬ ‫ا‬ $%‫وا‬ & !'# () * "+ ) ‫د‬ ‫آ‬ ‫ا‬ %‫ا‬ ‫ا‬ , - ‫ت‬ & /0# (‫آ‬ K A ١٢K % R * 627 50# / ‫و‬ 6‫ت‬ "9A(AMundisal
  • 6.
  • 7. ٦| P a g e anthraquinone-1 glycoside ‫وب‬ !" ‫ا‬ #K C& 50 ‫ا‬ 4 C T2 ‫ا‬ lidocaine-2 )‫ر‬( salicylic acid-3 ‫ب‬ ) ‫د‬ ‫و‬ 5 @!2 ٣‫ات‬ " & $% ! # ‫وح‬ "" ‫"%ج‬" ‫و‬ ‫ا‬ 5‫ت‬ "9A‫ن‬ ‫ده‬Salivex-l anthraquinone-1 glycoside T2 ‫ا‬ ‫وب‬ !" ‫ا‬ #K C& 4 C50 ‫ا‬ menthole-2 M I_‫را‬ ‫ر‬ "? D &‫ز‬ F 0 ‫ة‬Z " M & /K ‫-ت‬ 4‫ن‬ C 4-‫ا‬ (`. salicylic acid-3 ‫ب‬ ) ‫د‬ ‫و‬ 5 @!2 @") " & $% ! # ‫وح‬ ‫%ج‬ ‫و‬ ‫ا‬ 5‫ت‬ "9A‫ن‬ ‫ده‬piravex lidocaine-1 )‫ر‬( aminoacridine-2 (used clinically as a )antiseptictopical salicylic acid-3 @!2‫د‬ ‫و‬ 5‫ب‬ @") " & $% ! # ‫وح‬ ‫%ج‬ ‫و‬ ‫ا‬ 7.5 ‫ت‬ "9A gelSeptogel
  • 8. ٧| P a g e lidocaine-1 )‫ر‬( cetyl pyredinium-2 chloride thatantisepticIt is an kills bacteria and other microorganisms Chloroceresol-3 ‫دة‬ ‫آ‬ ‫دة‬ ‫ا‬ ‫ه‬ ‫#"م‬ $ ‫ات‬ %& $ ‫ا‬ '( ‫ذاذات‬ * ' +, ‫ا‬ - " ‫ا‬ @") " & ),- ‫ر‬ .-‫و‬ 4.5 ‫ت‬ "9A gelcanyon Active Ingredients Amlexanox...............2 mg (anti-inflammatory antiallergic immunomodulator used to treat recurrent aphthous ulcers (canker sores),) Inactive Ingredients Microcrystalline cellulose, Carbomer, (‫آ‬ K A ١٢K % (‫ا-آ‬ ‫م‬ 2& ‫ح‬ * ‫ج‬ 5 0 ‫ا‬ P # @ @"c ' ‫ا‬ ‫ا‬١٢ `‫آ‬d , M9 % ‫م‬ 2& -‫و‬ ( *‫أ‬ ‫ل‬ 0?e @١٢M9 % P # ‫أو‬ M K 9 ‫ذوى‬ M" "'? "g 40‫ت‬ "9A‫اص‬ *‫ا‬Alpthtabn lidocaine-1 )‫ر‬( jojoba oil-2 *It possesses microbial properties which discourage the growth of bacteria and fungal microbes *The oil also contains nutrients such as vitamin E, B complex vitamins, and minerals such as silicon, @") " & 50# / ‫ر‬ ‫و‬ 5‫ت‬ "9AgelJobadel
  • 9. ٨| P a g e 1-menthol ‫ع‬ 9 9 ‫ا‬ D&‫ز‬ @ % %‫ا‬ ‫ن‬ ! F "0 5 26 ‫ا‬ #K $ & ‫ن‬ C 4-‫ا‬ 2- thymol = ‫ا‬ @ ‫ج‬ 2) j‫د‬ ‫د‬ ‫وه‬ / ‫آ‬ ‫م‬ 2)‫و‬ ‫ت‬ & /0# 3-sodium fluride (Fluoride has been found to be helpful in reducing the number of cavities in the teeth) Saccharine sodium-4 , #I ‫ا‬ "6 ‫ا‬ 5 / ‫ا‬ , - 50 ‫ا‬ 5- Glycerin + Deionized water. 50# T? @") " & *""" """),- ! """""""""""""""""#‫و‬ $%. *‫رب‬ """"""""""""""12 3‫ا‬ """"""""""""""" ‫ا‬ 4""""" 5 6""""" ‫ا‬ """"" ‫ا‬ """""17‫را‬ """"""""""""""""""""""""" 8 ‫ب‬ """"""""""""8 ‫ا‬ ) 9. *‫رب‬ """"""""""""""12 """"""""""""""""" 5 ‫"4%ك‬"""""""""""""""""""" ‫ا‬ 6""" """ ‫وا‬ ‫ن‬ ‫ا‬. *6"" <9 ""12 ‫ظ‬ """ !‫و‬ """9 >$ ‫ن‬ ‫ا‬. 9.75 ‫ت‬ "9A orovex chlorhexidine-1 100mHCL125mg used in disinfectants and Active substance in healing wound 9K ‫وم‬Z# ‫ا‬ ‫ث‬ + 4 ‫ات‬ " & ),- ! #‫و‬ $% 3‫ت‬ "9AHexitol
  • 10. ٩| P a g e cetrimide25%-1 ?‫د‬ -‫ا‬ ), ‫م‬ . 5 ? ),- ‫ال‬ B-fungs‫و‬microbs lidocaine-2 )6 D -‫ر‬ .-( 3-sodium fluride (Fluoride has been found to be helpful in reducing the number of cavities in the teeth) ‫ث‬ + ‫ات‬ " & *""" """),- ! """""""""""""""""#‫و‬ $% *"""""" ‫ا‬ """""" ‫ن‬ ‫وا‬ 1.30 ‫ت‬ "9A Citrolin-F 1-Povidone iodine 200mg ‫ة‬ """ - ،‫ة‬ """),- G""" 9 ‫ذات‬ ‫دة‬ """- G"" , ‫ا‬ ‫وق‬ ""1 ‫وا‬ ‫وح‬ "" ‫ا‬ " G" ‫و‬K" ‫ا‬ G"2 ‫ا‬ ‫ت‬ "! ) ‫ا‬ 3‫ا‬ """"""" ‫ا‬ )44""""""" 5)"""""""2 L4 ‫ا‬( ‫ت‬ 2 , ‫وا‬ K A j 4‫وا‬ " & *<=9& - ‫ا‬ % ‫ء‬ 9+‫ا‬ ( I ‫ا‬ ‫ب‬ ) ‫ا‬ ‫%ج‬ ‫ا‬ ‫وى‬ ‫و‬ 3.20 ‫ت‬ "9A Betadine Mw 1-menthol ‫ع‬ 9 9 ‫ا‬ D &‫ز‬ @ % %‫ا‬ ‫ن‬ ! F "0 5 26 ‫ا‬ #K $ & ‫ن‬ C 4-‫ا‬ clove oil-2 (07 C ‫ا‬ D&‫ز‬–‫وح‬ # / ‫د‬ ‫و‬ 5 F0 3-thymol ‫م‬ 2)‫و‬ = ‫ا‬ @ ‫ج‬ 2) j‫د‬ ‫آ‬‫ت‬ & /0# ‫د‬ ‫وه‬ / 4-glycrein 50# T? @") " & $% ! # ‫"%ج‬""""""""""""""""" ‫و‬ "" ‫ا‬ ‫وح‬ "" """ N """),-‫و‬ $%. 3.75 ‫ت‬ "9A Oracin
  • 11. ١٠| P a g e 1-menthol ‫ع‬ 9 9 ‫ا‬ D&‫ز‬ @ % %‫ا‬ ‫ن‬ ! F"0 526 ‫ا‬ #K $ & ‫ن‬ C 4-‫ا‬ 2-methyl salisylate 0.06% 3-eucalyptol eucalyptol is used in flavorings, fragrances, and cosmetics 3-sodium fluride (Fluoride has been found to be helpful in reducing the number of cavities in the TEETH) @") " & """"" """""),- ! """""""""""""""""#‫و‬ $% 4.90 ‫ت‬ "9A oradent 1-menthol ‫ع‬ " ‫ا‬ O"2‫ز‬ B"- 6" ‫ا‬ ‫ن‬ L- Q"""" . """" ‫ا‬ 6"""" R""""D 2 ‫ن‬ ‫ا‬ clove oil-2 S"" $ ‫ا‬ O""2‫ز‬–‫وح‬ "". ""),- K3‫ا‬ ‫د‬ +-‫و‬ % Q .- 3-cinnamon ‫ت‬ """! ) ‫ا‬ """19 L- 6"""9 """ 5 2 L4 ‫وا‬ 2 , ‫ا‬ 4-methyl paraben *an anti-fungal agent often used in a variety of cosmetics and personal-care products. *It is also used as a food preservative " & j),- ! #‫و‬ $% 4.25 ‫ت‬ "9A Ora-zed
  • 12. ١١| P a g e 1-BENZYDAMINE 0.15% is a locally-acting nonsteroidal anti- inflammatory drug with local anaesthetic and analgesic properties for pain relief and anti- inflammatory treatment of inflammatory conditions of the mouth 9K ‫وم‬Z# ‫ا‬ 4٣ ‫ات‬ ),- ! #‫و‬ $% 2.5 ‫ت‬ "9A TANTUM VERDE HEXETIDINE 0.1% IT Is an anti-bacterial and anti-fungal agent commonly used in both veterinary and human medicine. It is a local anesthetic, astringent and deodorant and has antiplaque effects.[ (‫آ‬١٢ K % 50# / R *‫و‬ 627 5‫ت‬ "9AORALDENE 1-CHLOHEXIDINE used in disinfectants 2- Sodium citrate used as an acidity regulator in drinks 3- sodium borate used in biochemical and chemical laboratories to make buffers @") " & 50# / R *‫و‬ 627 14.75 ‫ت‬ "9A LYSOPLAC
  • 13. ١٢| P a g e S """""""" 2‫ود‬ ‫ا‬ """""""" -‫و‬ ! S""""""""""" U - 67 """"""""""" 3)٢ S""""""""""" 3‫إ‬ 6""""""""""" ‫آ‬ 9( ‫م‬ """"" $ -‫أ‬= )""""" -‫و‬ ! B -‫و‬ """"""""""""""""""""""""""""""""" ‫ا‬(((( ، ‫ل‬ """"" - ، ‫ل‬ 4 """""‫آ‬ 2 S"""""#Z! ، ‫ى‬ """"" U2‫إ‬ O"""""2‫ز‬ G""""" L - ‫ت‬ """"" ‫آ‬.... ‫ص‬ """""# S""""" ‫اغ‬ """""] ‫1%ب‬ """"""""""""""""""""""""""""""" ^.... ‫اص‬ """""""#‫أ‬‫1%ب‬ """"""" ^ """)!٠`٥""" -‫و‬ ! """ - 6"""""""""" 2 B -‫و‬ """""""""" ‫ا‬ B -‫و‬ """""""" ‫ا‬ """""""" -‫و‬ ! ‫ت‬ """4‫آ‬ - G""" - 6""" ‫إ‬ G""""""" ! ‫ا‬ ‫م‬ """"""" $ -b‫ا‬ G ‫ا‬ G 2 c.... G ‫ا‬ *1 2 ‫ادورال‬ ! 6c . ‫ا‬ ‫ء‬ de ‫ا‬ ‫ا‬ N.Q , c ‫و‬ +2‫أ‬ ‫ل‬ cb‫ا‬ 1 2.... 67 # ‫ا‬ ‫ام‬ . ^ *‫وا‬ ‫ص‬ # ‫1%ب‬ ^٤-٦ ، - 2 ‫ات‬ -‫اب‬i2 ‫ا‬ 69 j,4!.... ‫ت‬ 1 ‫ا‬ 69 ‫ام‬ . ^ % 9 ‫وى‬ ! G! k ‫ا‬:::: *‫وا‬ ‫ص‬ # 1 2 B 6 ‫إ‬ G S‫آ‬ )6k#‫أ‬ 1!٨‫اص‬ #‫أ‬ ‫م‬ ‫ا‬ 69 ‫1%ب‬ ^((((.... m 1 ‫وا‬ ),- ‫م‬ . 2 ‫أ‬ 2 n ‫ذ‬ R-‫و‬ ‫ر‬ )d ‫ا‬ ‫ء‬ 3‫أ‬ ‫ادورال‬ ! ‫إ‬ S 1 ‫ا‬ B- 6 ‫و‬b‫ا‬ G3%U ‫ا‬ G2 )# ‫ب‬ 4 b.... ) N3.75‫اص‬ #‫أ‬ 14TABS ‫1%ب‬ ‫ا‬ BradoralBradoralBradoralBradoral 1-lysozym 10mg 2-dequalinium 25mg *‫وا‬ ‫ص‬ # ‫1%ب‬ ^٤-٦ ‫اب‬i2 ، - 2 ‫ات‬ - ‫ا‬ 69 j,4! m 1 ‫وا‬ ),-) N‫ت‬ 9‫اص‬ #‫أ‬ 20TABS ‫1%ب‬ ‫ا‬ laryprolaryprolaryprolarypro
  • 14. ١٣| P a g e 1-dichlorobenzyl alchol ,antisepticmild able to kill andbacteria associatedviruses with mouth and .infectionsthroat 2-amylmetacresol antiseptican used to treat ofinfections mouththe throatand *‫وا‬ ‫ص‬ # ‫1%ب‬ ^٤-٦ 2 ‫ات‬ -‫اب‬i2 ، - ‫ا‬ 69 j,4! ‫ب‬ """"""""""") o ‫ول‬b‫ا‬ S""""""""""" ‫ة‬ 1 ‫وا‬ m 1 ‫ا‬ ‫ات‬p""""""" ‫ا‬:*‫اص‬ """""""#‫أ‬ """"""""""""""2 L4 ‫دة‬ """"""""""""""+- ‫ة‬ 1 ‫ة‬ ),- *""""" ),5 6""""" """"" 5 """"""""""""""""> 5‫و‬ Q""""""""""""""""$b‫ا‬ r ‫ا‬ *‫ة‬ """""""""""),- ‫اص‬ """""""""""#‫أ‬ G"""""""""""""" ‫وإزا‬ ‫ة‬ """""""""""""" 1 """"""""""""""""""" ‫ا‬ ‫ب‬ """"""""""""""""""") ‫إ‬ ‫ة‬ 1 ‫وا‬ ) N‫ت‬ 22‫اص‬ #‫أ‬ 20TABS ‫1%ب‬ ‫ا‬ StrepsilsStrepsilsStrepsilsStrepsils
  • 15. ١٤| P a g e
  • 16. ١٥| P a g e Nicomethanole hydroflouride A I ‫ا‬ T24 #K‫ن‬ ‫ا‬ S 511.50‫ت‬ "9AToothpast e ‫ن‬ 9%‫ا‬ ‫ن‬ 6 ‫ن‬ 9% % 2I ‫ا‬ EGYFLUOR gel,paste Many flour N 1 ‫ا‬ 6‫ن‬ ‫ا‬ S 521‫ت‬ "9AToothpast e ‫ن‬ 9%‫ا‬ ‫ن‬ 6 ‫ن‬ 9 % % 2I ‫ا‬ Sensodyne 100gm 12‫ت‬ "9A Sensodyne 55gm
  • 17. ١٦| P a g e
  • 18. ١٧| P a g e Vit C- 2 ? ‫وا‬ ? -, `# ‫ا‬ Im #K ‫ظ‬ 0I# `# ‫ا‬ F&Z7 4 @& !) "# K , K 2& 9 ‫ا‬ ‫ء‬ +‫ا‬ ‫ن‬ 9%-‫ا‬ 8.00‫ت‬ "9A‫اص‬ #‫أ‬ 20TABS amovit-c 1000 Vit C- 2 ? ‫وا‬ ? -, K 2&‫و‬ `# ‫ا‬ & C) ‫ن‬ 9%-‫ا‬ @& !) "# K 4.00‫ت‬ "9A‫اص‬ #‫أ‬ 20TABSCevarol 500mg Vit C- 2 ? ‫وا‬ ? -, K 2&‫و‬ `# ‫ا‬ & C) ‫ن‬ 9%-‫ا‬ @& !) "# K ‫ـ‬ ، ‫ا‬ ‫ج‬ ‫إ‬ ‫ي‬ ‫ا‬ ‫و‬ ‫وا‬ ‫ن‬ !‫ا‬ " # $ % #& ،‫م‬ %( ‫ا‬ ،$) ‫ا‬ ،‫ن‬ *+,‫ا‬ 12.00 ‫ت‬ "9A ‫ار‬ 9Vitacid-c1g
  • 19. ١٨| P a g e
  • 20. ١٩| P a g e chymotrypsin + trypsin ‫م‬p$ L ‫ا‬ ‫ه‬‫ت‬ 2p$‫ا‬ proteolytic ‫ت‬ 5‫و‬ 4 ‫ا‬ L ! )$‫ا‬ m2 c B ‫ال‬ K 3Z ! exudative phaseB- inflamation - 5 Sk1 49 Speptidic chainsK !‫و‬ ‫ن‬ L ‫ه‬ t 9 inflamation ‫ص‬ #٣- 2 ‫ات‬ - )G ! S‫آ‬b‫ا‬ S4#( B-‫و‬‫دة‬ 2‫ز‬ BL ‫ا‬ G 1 ‫ا‬ G ‫ا‬ ١-‫ن‬ ‫ا‬ R w ! ٢-U ‫ا‬ ‫ت‬ ! ) ‫ا‬ ٣-‫ن‬ ‫وا‬ ‫ا‬ ‫ت‬ ! ) ‫ا‬ ٤-‫ا‬ N ‫اى‬ ! ‫او‬ n""""""" ‫ا‬ ‫او‬ """"""" ‫ا‬ 6"""""""9 ‫ن‬ ‫ا‬ 15‫ت‬ "9A‫اص‬ #‫أ‬ 20TABS Ambezim-g chymotrypsin + trypsin ‫ص‬ #٣- 2 ‫ات‬ - )G ! S‫آ‬b‫ا‬ S4#( BL ‫ا‬ B-‫و‬‫دة‬ 2‫ز‬ G 1 ‫ا‬ G ‫ا‬ ١-‫ن‬ ‫ا‬ R w ! ٢-U ‫ا‬ ‫ت‬ ! ) ‫ا‬ ٣-‫ن‬ ‫وا‬ ‫ا‬ ‫ت‬ ! ) ‫ا‬ ٤-‫ا‬ N ‫اى‬ ! ‫او‬ n""""""" ‫ا‬ ‫او‬ """"""" ‫ا‬ 6"""""""9 ‫ن‬ ‫ا‬ 20‫ت‬ "9A‫اص‬ #‫أ‬ 20TABS Alphintern
  • 21. ٢٠| P a g e chymotrypsin + trypsin 1 ---- 2222- 2 G 4-‫أ‬ B 1 ‫ا‬ m2 c B 6 .5 ‫ان‬ 6 ‫إ‬ 6 + ‫ا‬ G D ‫ا‬ ‫اض‬ b‫ا‬.... ••••‫ت‬ 1 ‫ا‬ 69 G -p ‫ا‬:١-٢6 ‫إ‬ ٣4 ‫أ‬ ‫ات‬ -.... ‫ت‬ 69 G- G k! # ‫ى‬i ‫ا‬ 6 D ‫ا‬ ‫رم‬ ‫ا‬ G ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ 6 2 18‫ت‬ "9A5‫او‬ B ‫ت‬ 4-‫ا‬ Alpha Chymotrypsin 1-THIOTEX ACID 300MG o" ‫آ‬ "` R 4 ١_B2 L5 p 12 )S-k ‫ا‬ B2 L5( S ] 5 B- B 12 n i ‫ب‬ k ‫ا‬ 2-B- B 12 B $ ‫ا‬ B2 L5 B2 L5 m2 c R ‫ا‬ ‫%و‬)‫اوآ‬ B N‫و‬( DOSE : in severe cases 300-600 mg. - by iv. Injection daily for two to four weeks, after that oral tablets should be used as 300 mg daily as a maintenance dose. *I ‫ا‬ , ‫اص‬ *-‫ا‬ j 4‫وا‬ j &‫د‬ ‫ا‬ ‫ر‬ /0 ‫ا‬ pC, ‫ب‬ =K-‫ا‬ ‫ب‬ ‫ا‬26‫ت‬ "9A‫اص‬ #‫أ‬ 20TABS THIOTEX 300MG 30‫ت‬ "9A‫اص‬ #‫أ‬ 20TABS THIOTEX 600MG
  • 22. ٢١| P a g e
  • 23. ٢٢| P a g e ‫آ‬ ‫ا‬‫ا‬ ‫ا‬‫ا‬‫ا‬‫ع‬ ‫ا‬‫واء‬ ‫رى‬ ‫ا‬ ‫ا‬ 1-metronidazol & !'# ‫دة‬ M"_‫ا‬ ‫ه‬ ‫ا‬ *One of the antibiotic that kill bacteria by in hibition of nuclic acid OF BACTERIA 30*" ‫آ‬ S"L - S""""""" , ‫ا‬ ‫وزن‬ B""""""- *K"""" !S"""" c """" """$‫وز‬ G """ ? """ ١٠"""""42 5 """"" ‫آ‬. *K""""""""""""""""""""""" 42٣٠ K""""9 G!‫و‬ """"+-١٠ ‫وي‬ "" 2٣٠٠"" - """""""""""""""""""""""""""""""""" - 2. *‫اب‬ """"d ‫ا‬ p"""" ‫آ‬ 5‫و‬ ١٢٥S""""L """" -٥ S"""""""""""""""""""""""""""""""""""""""-: *S"‫آ‬ ‫أذا‬5"! K" - ٥"""""""""""""""""""""""""""""""" - ‫ازول‬ """"""""""""" $‫و‬ -. *‫م‬ . """""""" 2 ‫أذا‬١٢ B""""""- """""" - 2 S""""""- S"""""""""""""""""""""""""""""" N%9. *‫أي‬٤S-٣‫ات‬ - - 2 *‫ن‬ 9%-‫ا‬ ‫وي‬ K)‫أذا‬ & !' ‫وي‬ K D7 ‫آ‬ M"_‫ا‬ ‫-ه‬( *M & ! ‫ا‬ 50 ‫ا‬ MI_‫را‬ & !' ‫ا‬ T'2 M"_‫ا‬ ‫ه‬ ‫ا‬. 6‫ت‬ "9A ‫اص‬ *‫أ‬ 20 TABS Flagyl 500mg .505 ‫ت‬ "9A‫اص‬ *‫أ‬ 20 TABS Flagyl 250mg 04.5 ‫ت‬ "9A ‫اب‬ rFlagyl 125mg *U07 T"‫آ‬ ‫ا‬ F 2 ‫ا‬ K 6 ‫ا‬ U07 ) C 2 ‫ا‬ *‫وي‬ K‫ن‬ 9%-‫ا‬)‫أذا‬ & !' ‫وي‬ K D7 ‫آ‬ M"_‫ا‬ ‫-ه‬( *M & ! ‫ا‬ 50 ‫ا‬ MI_‫را‬ & !' ‫ا‬ T'2 M"_‫ا‬ ‫ه‬ ‫ا‬. 2.90"9A‫اص‬ *‫أ‬ 20 Flagicure forte 500mg 1.60 "9A ‫اص‬ *‫أ‬ 20 TABS Flagicure 250mg
  • 24. ٢٣| P a g e 1-amoxycillin 2-flucloxacillin ‫ن‬ & "4 ‫دان‬ ‫ه‬ ‫ا‬s‫وه‬"#K , p"# ‫ا‬ ‫ج‬ K , " K ‫ت‬ ‫و‬ !" ‫وى‬ ‫ا‬ ' 2 ‫وا‬ 'A ‫ا‬ ‫ام‬ 6 ‫ا‬ c'= ‫ا‬. *@"##"% 2‫آ‬ #‫آ‬ #0 ‫ا‬ flucloxacillin)( ‫ى‬ * "+ ) j‫ز‬ 0 ‫ا‬ ‫ت‬ ‫و‬ !" ‫ا‬ 5&Z7-Z"9"##"29 penicillinase *‫ل‬ 0? ‫و‬ ‫ر‬ '!# ‫ق‬ ,١٨K 2'‫آ‬500mg (‫آ‬٦-٨‫او‬ ‫ت‬ K % ‫ص‬ *1g(‫آ‬١٢ j r T24 K % ‫وى‬ ‫ا‬ *4 ‫ل‬ 0?-‫ا‬١٠ ‫ات‬ 9%١٢٥56- ٢٥٠(‫آ‬ (٨ ‫ت‬ K % *‫ن‬ 9%-‫ا‬ ‫وي‬ K 50 ‫وا‬)'A & !' ‫ا‬ ‫ام‬ 6 ‫ا‬ ' %‫و‬ ‫ام‬ 6 ‫ا‬ "_‫ا‬ ‫ه‬ ‫ا‬ & !' ‫وا‬( *‫وح‬ 6 ‫ا‬ ‫ث‬ #) M"4‫ا‬ 6 ‫ا‬ ‫ت‬ "# ‫ا‬ 7.5 ‫ت‬ "9A ‫اص‬ *‫أ‬ 20 TABS Flumox 250 mg 18‫ت‬ "9A 20 TABS ‫اص‬ *‫ا‬ Flumox 500 mg 24‫ت‬ "9A ‫اص‬ *‫أ‬ 20 TABS Flumox 1G 13‫ت‬ "9A‫اب‬ rFlumox 100 ( T"‫آ‬ ‫ا‬ U07K 6 ‫ا‬ U07*‫ن‬ 9%-‫ا‬ ‫وي‬ K50 ‫وا‬ )'A & !' ‫ا‬ ‫ام‬ 6 ‫ا‬ ' %‫و‬ ‫ام‬ 6 ‫ا‬ "_‫ا‬ ‫ه‬ ‫ا‬ & !' ‫وا‬( *‫وح‬ 6 ‫ا‬ ‫ث‬ #) M"4‫ا‬ 6 ‫ا‬ ‫ت‬ "# ‫ا‬ 6‫ت‬ ) NFlumox 1G
  • 25. ٢٤| P a g e @"##"2"2‫آ‬ ‫أ‬ "%‫أ‬ o"9" ", ‫.وآ‬ @ @"##"2"2‫آ‬ v‫ا‬ 7‫أ‬ ‫وف‬ ‫ا‬ ‫ت‬ 6 ‫ض‬ & ‫ن‬ !, ‫م‬ ‫-آ‬ "' ‫ا‬ ‫د‬ A‫و‬ ‫وي‬ ‫ا‬ @ ‫دة‬‫ر‬ C) M , ‫ع‬ 9 ‫ا‬ ‫ا‬s‫ه‬ 4‫د‬ P#K ‫وم‬ C ‫ا‬ & !' ‫ا‬ @ j‫ود‬ @"##29'# ‫ن‬ !"‫ه‬ "%‫أ‬ o"9" ", ! ‫.ا‬ Clavulinic acid ‫ر‬ 4L ‫اص‬ #b‫:ا‬ 625 ١٠٠٠(‫آ‬ 56 ١٢‫ة‬ MK %٧‫م‬ &‫أ‬ M# ‫آ‬ *‫ن‬ 9%-‫ا‬ ‫وي‬ K50 ‫وا‬ )'A & !' ‫ا‬ ‫ام‬ 6 ‫ا‬ ' %‫و‬ ‫ام‬ 6 ‫ا‬ "_‫ا‬ ‫ه‬ ‫ا‬ & !' ‫وا‬( *6 ‫ا‬ ‫ث‬ #)‫وح‬ M"4‫ا‬ 6 ‫ا‬ ‫ت‬ "# ‫ا‬ 58‫ت‬ "9A‫اص‬ *‫أ‬ 14TAB S Augmentin1g 35‫ت‬ "9A‫اص‬ *‫أ‬ 10TAB S Augmentin625 mg 375‫ت‬ "9A‫اص‬ *‫أ‬ 10TAB S Augmentin375 mg 11.5‫ت‬ "9A9C4 Augmentin600 mg T"‫آ‬ ‫ا‬ U07‫ل‬ c{ ‫اب‬ d ‫ا‬: B-١-٦‫ات‬: 50*@ 56 Z"‫آ‬ )@"##2"2‫آ‬ -‫ا‬ P#K M 2C 56‫آ‬ (! M+ + ‫أو‬ @" K A. *7‫وز‬ (0? P9 ١٢y & 56‫آ‬٤( Z"‫آ‬ ) @٣١٢M+ + " & ‫ات‬. B- K ‫أ‬٦‫ات‬: 5*‫ات‬ M+ + ( Z"‫آ‬ ) @ " & ٤٥٧ ‫ام‬ %-‫ا‬ U0728‫ت‬ "9A‫اب‬ r Augmentin312 mg/5ml 37‫ت‬ "9A‫اب‬ r Augmentin457 mg/5ml
  • 26. ٢٥| P a g e T"‫آ‬ ) U07 ‫ال‬ Augmenti n ‫ر‬ '!# ‫اص‬ *v‫*ا‬ 625 mg (‫آ‬١٢j٧‫م‬ &‫ا‬ *(‫آ‬ ‫او‬١٢K %١‫ام‬ A j & z ‫ا‬ ‫وى‬ ‫ا‬ 4 , ‫ب‬ *‫ن‬ 9%-‫ا‬ ‫وي‬ K 50 ‫وا‬)& !' ‫ا‬ ‫ام‬ 6 ‫ا‬ 'A ‫ام‬ 6 ‫ا‬ ' %‫و‬ & !' ‫وا‬ "_‫ا‬ ‫ه‬ ‫ا‬( *‫ث‬ #)‫وح‬ 6 ‫ا‬ M"4‫ا‬ 6 ‫ا‬ ‫ت‬ "# ‫ا‬ *6) 9 ‫ا‬ ‫ت‬ -‫ا‬ & !' ‫ا‬ @K)T ‫ا‬ `# ‫ا‬( 25‫ت‬ "9A‫اص‬ *‫أ‬ 8 TABS Hibiotic 1g 26‫ت‬ "9A‫اص‬ *‫أ‬ 10 TABS Hibiotic 625mg 19‫ت‬ "9A‫اص‬ *‫أ‬ 10 TABS Hibiotic 375mg U07 T"‫آ‬ ‫ا‬ B-١-٦‫ات‬ 50@ 56Z"‫آ‬ ) 56‫آ‬ (! @"##2"2‫آ‬ -‫ا‬ ‫أو‬ @" K A P#K M 2C M+ +. 7‫وز‬ (0? P9١٢56‫آ‬ y &٤Z"‫آ‬ ) @ (٣٢٠ ٣" & ‫ات‬ B- K ‫أ‬٦‫ات‬: 5(٣@ " & ‫ات‬ Z"‫آ‬ )٤٦٠. @ '‫أآ‬ (0/ ‫ا‬ ‫وزن‬ ‫ن‬ ‫آ‬ ‫اذا‬ ٤٠‫ر‬ '! ‫ا‬ MK A syd& 56‫آ‬ ‫ام‬ %-‫ا‬ U07‫ت‬ "9A23‫اب‬ rHibiotic 460mg ‫ت‬ "9A32‫اب‬ rHibiotic 460mg
  • 27. ٢٦| P a g e ‫ز‬p1- ‫ص‬ # S‫آ‬ 6 ‫ى‬ 12 B ‫آ‬ -‫أ‬ ‫رات‬ ‫ه‬ ‫اى‬ 5 ‫آ‬ ‫آ‬ 9‫و‬ ‫م‬ 2‫د‬ ] B ‫رات‬ ‫ه‬ $ - ‫دل‬ 2: -B ‫آ‬ -‫أ‬ 500- ‫آ‬ ‫آ‬ 9 B2500- B e 4 ‫ا‬ *(‫آ‬ ‫ص‬ *٨@! &‫و‬ ‫ت‬ K % (‫آ‬ / & ‫ان‬٦, ‫ت‬ K % j & z ‫ا‬ m-‫ا‬ 4 B B- ‫ل‬ c% ‫ا‬ ١٦-٨ *(‫آ‬ ‫ص‬ * F=7 / &٨ / & ‫ان‬ @! &‫و‬ ‫ت‬ K % (‫آ‬ ‫ص‬ * F=7٦‫ت‬ K % `‫ا-آ‬ m-‫ا‬ 4 , j‫ر‬ /y ١-‫ن‬ ‫ا‬ ‫اج‬ w ٢-U ‫ا‬ ‫ب‬ ) ‫ا‬ ٣-‫وى‬ ‫ا‬ 2 L4 ‫ا‬ ‫ت‬ "9A 20‫اص‬ *‫أ‬ 10 TABSFloxamo 1 M"#K , 5A "2‫دروآ‬ 0"% ‫ل‬ ‫ج‬ ‫دة‬ ‫ا‬ MK 6 ‫ا‬ ‫ب‬ ‫ا‬50 ‫ا‬ 627‫وا‬ ‫ن‬ 9%-‫وا‬ ‫ه‬١‫ة‬ 4‫وا‬ MK 6‫آ‬ ‫ام‬ A #K M 2C ‫او‬ ‫م‬ " ‫ا‬ , ‫ة‬ @" &‫و‬ 2 @" K A١٠ (*-‫ا‬ #K ‫م‬ &‫ا‬ *‫وى‬ ‫ن‬ ‫وا‬ ‫ا‬ ‫ت‬ "9A 8‫اص‬ *‫أ‬ 8 TABS Curisafe
  • 28. ٢٧| P a g e Amoxycillin as 250mg, 500mg and 1000mg injections. ‫وى‬ ‫ا‬ 69 2 L4 ‫ا‬ *G 4‫آ‬٥٠٠- S‫آ‬٨‫ت‬ *B 4‫آ‬٥٠٠ S‫آ‬ -١٢G 2 # ‫ا‬ 69 ‫م‬ . 5 *9C4١‫ر‬ '!# ‫ام‬ A *9C4500‫ام‬ 6 ‫ل‬ 0? (for mor information visit this web) http://www.me dsafe.govt.nz/pr ofs/datasheet/i/i biamoxinj.pdf *prevent blood infection due to procedures such as dental extractions in patients who are at risk of developing endocarditi s *S4# ‫م‬ . 5 ‫ن‬ ‫ا‬ R w B- 2 # endocarditi s 6D - 69 6 1 ‫ا‬ -p5 -‫و‬ ‫ا‬ & !' ‫ا‬ ‫وى‬ ‫ا‬ * "9A 3.70‫اص‬ *‫أ‬ 12 TABS IBIAMOX25 0 mg "9A 8.00‫اص‬ *‫أ‬ 12 TABS IBIAMOX50 0 mg
  • 29. ٢٨| P a g e
  • 30. ٢٩| P a g e @" `" ‫و‬ ) ‫رو-ك‬ "‫آ‬٣٠ 56 Ketorolac tromethamin ‫م‬p $ L ‫وا‬ ‫اص‬ . ‫:ا‬ ‫-ك‬ "‫آ‬MK 6 P ‫إ‬ P 9& "g ‫ت‬ |‫ا‬ ‫دات‬ M&‫ود‬ " 2 ‫ا‬ NSAIDs o s ‫و‬ P &Z7‫إ‬ p"'`) P#K (" & , ‫ز‬ 9"6"2‫اوآ‬ #!"%١‫و‬٢ (COX-1+COX-2) ‫ق‬ ?-‫ا‬ P#K ‫اه‬ *‫ا‬ ' &‫.و‬ B 1 ‫ا‬ N O15 B e 4٦٠-: ‫-ك‬ "‫آ‬@") @C4 P=*‫ا‬ I " &٤ C4‫ة‬ ‫و‬ " & @ ‫ي‬ =* ‫ام‬ %‫إ‬٥&‫أ‬‫م‬ ‫ال‬ ‫ق‬ 9٦٠-: ‫-ك‬ "‫آ‬ ‫ل‬ ' ‫أ‬ F=7 I " & @") P=*‫أ‬٤" & @C4 ‫ي‬ =* ‫ام‬ %‫إ‬ ‫ة‬ ‫و‬ ٥pC, ‫م‬ &‫أ‬ ‫ى‬ # BL - ‫ن‬ ‫وا‬ ‫ا‬ "9A 10‫اص‬ *‫أ‬ 20 TABS Ketolac 10 "9A5 @C4Ketolac ‫م‬ 5 ! ‫ك‬ 9 L2‫.د‬ Diclofenac Potassium 25-50@ 56 (‫آ‬ ‫ص‬ *‫أ‬ ‫م‬ , ‫آ‬٨ ‫ت‬ K %. ‫ول‬ ! |k 2‫و‬ ! ‫اص‬ #‫أ‬ ‫9%م‬ ‫آ‬ ? 3Z ‫ت‬ 4N ‫ا‬ ‫ة‬ ‫ا‬ K. -‫ن‬ b‫ا‬ ‫م‬ ‫ا‬ GU ‫وا‬. "9A 5‫اص‬ *‫أ‬ 10TABCata lam50mg 9"9A‫اص‬ *‫أ‬ 10 TABS Cata lam25mg ‫ي‬ I) M'#K A & P#K٣‫-ت‬ ' ‫أ‬ P#K ‫ي‬ I) M'#K‫و‬٦ % ‫-ت‬ ' ‫أ‬ 9 (‫آ‬ P, M ' -‫ا‬ ٤}٧M ' e "9A. @C4Cataflam75mg
  • 31. ٣٠| P a g e ‫ك‬ 9 L2‫د‬ ‫م‬ 5 !. Diclofenac Potassium B e 4 ‫ا‬: ‫أو9%م‬ ‫ل‬ ‫إ‬ 2٥٠ ‫اص‬ #‫أ‬٣‫ات‬ -- 2 G2 # ‫ت‬ 4N ‫ا‬ ! ‫ة‬ ‫ا‬ K ? 3Z5 B-. O15 ‫ل‬ c{١٢ -: ‫أو9%م‬ ‫ل‬ ‫إ‬ 2٢٥ Kk#‫ا‬ 1! ‫اص‬ #‫أ‬٣ - 2 ‫ات‬ -. ‫أو9%م‬ ‫ام‬ . ‫أ‬ R 2 ‫ل‬ c{ - 5 ‫اص‬ #‫أ‬ O15٩2‫و‬ ‫ات‬ ‫ع‬ #‫أ‬ ‫ام‬ . ‫إ‬ B ‫دو‬ ‫أو‬ B2‫ر‬ 9 - !.. -GU ‫وا‬ ‫ن‬ b‫ا‬ ‫م‬ ‫ا‬"9A 5.5‫أ‬‫اص‬ * 10TAB Oflam 50 "9A 3.5 ‫اص‬ *‫أ‬ 10TAB Oflam25 ‫م‬ "% ) ‫ك‬ 9", #!&‫د‬ – Diclofenac Potassium. B e 4 ٧٥-١٥٠, 56 j 4‫وا‬ K 6‫آ‬ ‫م‬ " ‫ا‬ #K 2C ‫او‬ ‫ت‬ K A K @ ‫ل‬ 0?-‫ا‬)١- ١٢(9%١-٣56 #K 2C ‫م‬ " ‫ا‬ , ‫ت‬ K A -‫ن‬ 9%-‫ا‬ $#y -‫-ت‬ 4 , ‫ح‬ z)‫وا-ر‬ ‫ب‬ -‫ا‬ ‫ت‬ "# ‫ا‬ 5 ~ ‫ا‬ M"4‫ا‬ 6 ‫ا‬ 6"9A‫اص‬ *‫أ‬ 20TAB Dolphin K25 mg 8"9A‫اص‬ *‫أ‬ 20TAB Dolphin K50 mg 6.5"9A102'‫آ‬Dolphin K75 mg 6.75"9A3@C4Dolphin K75 mg/3m
  • 32. ٣١| P a g e B 9‫و‬ ! ‫آ‬ Ketoprofen*M 2'‫آ‬٣‫ات‬ (‫ا-آ‬)٥٠•( *( K M9C4" & *MC #٣‫ات‬ ١-‫ت‬ ‫د‬ ٢-‫-م‬ @!2 ٣-‫-ت‬ 4 , K 2 F7-‫ا‬ ‫ت‬ ‫ا‬ ‫ة‬ 69I ‫وا‬ ‫وا-ذن‬ ‫ن‬ 9%-‫ا‬ ‫ب‬ ‫وا‬ 1.75 "9A‫اص‬ *‫أ‬ 10TAB Ketolgin 25mg 2 "9A‫اص‬ *‫أ‬ 10TAB Ketolgin50m g 8 "9A10 2'‫آ‬Ketolgin 200mg 3 "9A3 @C4Ketolgin100 mg B 9‫و‬ ! ‫آ‬ Ketoprofen *M 2'‫آ‬٣‫ات‬ (‫ا-آ‬)٥٠•( *( K M9C4" & -GU ‫وا‬ ‫ن‬ b‫ا‬ ‫م‬ ‫ا‬3.753.753.753.75) N‫اص‬ *‫أ‬ 10TAB Ketofan 25mg 5555‫ت‬ ) N20 2'‫آ‬Ketofan 50mg 5555‫ت‬ ) N10 2'‫آ‬Ketofan 75mg 3333‫ت‬ ) N3@C4Ketofan 100mg G """"""""""" 4‫آ‬ S"""""""""""‫آ‬ ‫ى‬ """" 15 G"""" 5% N 6""""""""":::: 200200200200"""""" - ‫اب‬i- B 9‫و‬ ! 42‫ا‬ 1- 2@K M 2'‫آ‬ ( ‫آ‬ 5 0 ‫ا‬ S & ?٤- ٦9K ‫أو‬ ‫ت‬ K % ‫وم‬Z# ‫ا‬. @! 2 @" 0" ‫را‬ ‫€-م‬ $& % ‫ل‬ , R, y‫و‬ ‫د‬ ‫و‬ ‫ارة‬ I# ‫ت‬ - 3.503.503.503.50) N‫اص‬ *‫أ‬ 10TAB Rapifen200 mg
  • 33. ٣٢| P a g e 1-paracetamol 350mg 2-ibuprofen 200mg B e 4 ‫ات‬ - ‫3%ث‬ ‫ص‬ # - 2 ‫ل‬ c% ‫"%ث‬""3 ‫ص‬ """# Q"""k$ - 2 ‫ات‬ - GU ‫وا‬ ‫ن‬ b‫ا‬ ‫م‬ ‫ا‬2.752.752.752.75) N‫اص‬ *‫أ‬ 20TAB Megafen ibuprofen-1‫ر‬ """""""""4L:S"""""""""+ 2 """"" ! ?i"""""w‫ا‬‫م‬ """"" , ‫ا‬ 6"""" ?‫ر‬ """"3‫ا‬ S"""" G""""""" N‫و‬ ? """"""" ‫ا‬ ‫ر‬ """""4L٤٠٠""""" - ‫ت‬ O S‫آ‬ ‫ل‬ c%:S+ 2 K‫وه‬ # G N ٢٠٠O S‫آ‬ - ‫ت‬ ‫3""""""""%ث‬ ‫اب‬ """"""""€ ‫او‬ - 2 ‫ات‬ - GU ‫وا‬ ‫ن‬ b‫ا‬ ‫م‬ ‫ا‬ B L ‫ا‬ Sk - ‫م‬ ‫ا‬ 6.756.756.756.75) N‫اص‬ *‫أ‬ 20TAB Brufen200 mg 13.5013.5013.5013.50) N‫اص‬ *‫أ‬ 20TAB Brufen400 mg 15151515) N‫اص‬ *‫أ‬ 20TAB Brufen600 mg 6666) N‫اب‬ rBrufen100 mg /150ml
  • 34. ٣٣| P a g e ‫ك‬ 9 L2‫د‬ ‫م‬ 2‫د‬ ] ‫ر‬ """""""4L ‫ا‬:٧٥-١٥٠ ‫م‬ " ‫ا‬ P , 5 c#، ‫او‬ ‫ة‬ 4‫وا‬ M K 6 M K‫ز‬ ‫و‬ M 2C ‫م‬ " ‫ا‬ ‫ل‬ y. ‫ل‬ c ‫ا‬:٣(! •# S& ? @K ‫م‬ " ‫ا‬ P, 56‫آ‬ #K M 2C 50 ‫ا‬٢-٤ ً" & ‫ات‬. ‫ل‬ `:(0/ ‫ا‬ ‫وزن‬ ‫ن‬ ‫آ‬ ‫إذا‬ ٣٠/ & 56‫آ‬٦٠‫إ‬ ٩٠#K M 2C •#٢- ٤P & ‫ات‬ -‫ل‬ o‫ا‬ 6 ‫دوا‬ -‫ن‬ b‫ا‬ ‫م‬ ‫ا‬ GU ‫وا‬. 11.2511.2511.2511.25) N‫اص‬ *‫أ‬ 30TAB Voltaren 25 11.9011.9011.9011.90) N‫اص‬ *‫أ‬ 20TAB Voltaren 50 28) N‫اص‬ *‫أ‬ 10sr TAB Voltaren- sr 100 12.75) N3@C4Voltaren 75 Ibuprofen‫ر‬ """4L ‫ا‬:‫واء‬ ‫ا‬ s y‫أ‬ M &‫و‬ y ‫ة‬ P #K ( ,‫أ‬ P / & ‫إن‬ ‫و‬ ‫ص‬ = ‫أ‬ ( 0 ‫ا‬ @ ‫ن‬ ‫آ‬ ‫م‬ / ‫ا‬ $ js y‫أ‬ ‫ر‬ ‫ا‬ j "+d ) ( "#C ‫ة‬ ‫ا‬ P#K. P / &٤٠٠5 6 D % ‫أو‬ $ ‫أر‬ ( ‫آ‬ ‫ت‬ K %. ‫ا‬s ‫ه‬ ‫َم‬ 2ُ& ‫ج‬ ُ‫ء‬‫…وا‬ ‫ا‬ ‫ب‬ ‫ا‬( ِm 0 ‫ا‬ B """""""L ‫ا‬ S"""""""k ‫آ‬ """"""" ‫ا‬ Q""""""" . ‫و‬ S] ‫ا‬ K9. 4) N‫اص‬ *‫أ‬ 10sr TAB Ibuprofen 400mg Tabs
  • 35. ٣٤| P a g e Mefenamic acid٥٠٠‫ام‬ N S-٣ - 2 ‫ات‬ -. *T4 = ‫ا‬ 5 v‫ا‬ ‫ب‬ -‫ا‬ ‫أو‬ ‫رم‬ # ‫ت‬ m|‫ا‬ $ ' & ‫ي‬s ‫ا‬ ‫أو‬ M" ‫ا‬ M"4‫ا‬ 6 ‫ا‬. ‫ت‬ ‫إ‬0 ‫ا‬(m -*‫ارة‬ I# R, y. 5.50) N‫اص‬ *‫أ‬ 10 TAB Mefenam 500mg Lornicam*@ ‫ص‬ * $ #'& ‫م‬ !"7‫ر‬٨5 6 M & % ‫اص‬ *‫ا‬ " ‫آ‬ $ @ ‫و‬s ‫ا‬ @ ' % 9 (_‫ا‬ 2 ‫ا‬. *‫ول‬ 9) 5 & , ‫اص‬ *-‫ا‬ ‫ت‬ K A@ ٨T 6& -‫و‬ 5 6 I ‫ا‬ / ) ‫ح‬ 2 ‫ا‬ =*-‫ا‬ ‫ت‬ K 6 ‫ا‬ @ ‫وه‬١٦" & 56 p') ‫ا‬ 5 -‫ا‬ ‫ب‬‫رج‬ y ( m 0 ‫ا‬‫ج‬ ‫و‬ 5 -‫ا‬ ‫اض‬ K‫ا‬ , ‫ب‬ -‫وا‬ ‫ب‬ -‫ا‬ ‫-ت‬ 4 Y ‫ا‬ ‫ب‬ ‫وا‬ # =0 ‫ا‬ ( =0 ‫ا‬ 7‫ا‬ + ‫ا‬. 13.00) N‫اص‬ *‫أ‬ 10 TAB Lornicam Rapid tablets
  • 36. ٣٥| P a g e
  • 37. oral gel Daktarin oral gel Miconaz 2% oral gel Micoban 2% - 2 ‫ات‬ - ‫3%ث‬*‫"""""""""""""""""%ج‬ ‫ا‬ ‫ت‬ 2 ,9 *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ا‬ 2 $ ‫آ‬ 18‫ت‬ "9A - 2 ‫ات‬ - ‫3%ث‬ *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ت‬ 2 ,9 *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ا‬ 2 $ ‫آ‬ 4,70‫ت‬ "9A - 2 ‫ات‬ - ‫3%ث‬ *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ت‬ 2 ,9 *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ا‬ 2 $ ‫آ‬ 4,90‫ت‬ "9A ٣٦| P a g e Miconazole nitrate- 2 ‫ات‬ - ‫3%ث‬ Miconazole nitrate- 2 ‫ات‬ - ‫3%ث‬ Miconazole nitrate- 2 ‫ات‬ - ‫3%ث‬
  • 38. ٣٧| P a g e Nystatin mechanism NYSTATIN bind to sterols in the fungal cell membrane... RESULTING IN disturbances in cell membrane function as selective barrier ,THIS LEADS TO loss of essential cellular constituents - 2 ‫ات‬ - ‫3%ث‬ *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ت‬ 2 ,9 *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ا‬ 2 $ ‫آ‬ 3.50"9AOral drops Nystatin 30 ml Nystatin S 2 ‫ا‬ ‫م‬Z7 !" ‫ا‬ U07 .‫آ‬٨‫ت‬ 0/٦ & ‫ا‬ 3$4 ‫ت‬ 0 $ ‫ا‬ ‫او‬ *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ت‬ 2 ,9 *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ا‬ 2 $ ‫آ‬ 4‫ت‬ "9AOral drops Fungistatin 30ml Nystatin r $‫م‬p$ L ‫ا‬ m! ‫ا‬ .‫آ‬٨‫ت‬ 0/٦ & ‫ا‬ 3$4 ‫ت‬ 0 $ ‫ا‬ ‫او‬ *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ت‬ 2 ,9 *‫"""""""""""""""""%ج‬ ‫ا‬ ‫ا‬ 2 $ ‫آ‬ 4‫ت‬ "9AOral drops MYCOSTATI N 30 ml
  • 39. ٣٨| P a g e
  • 40. ٣٩| P a g e Calcium glubionate 1200mg5ml - 2 ? ‫وا‬ ? -•"""""""""""""""""""""" $ ‫م‬ L ‫ا‬ ‫ى‬i"" ‫ا‬ ‫ل‬ "" c ‫ا‬ 6"""""" ‫ا‬ ‫دى‬ """"""2 ‫ر‬ """") w """"5 ‫ن‬ ‫ا‬ 5‫ت‬ "9A ‫اب‬ rHi-cal 100ml Calcium- 2 ? ‫وا‬ ? -•"""""""""""""""""""""" $ ‫م‬ L ‫ا‬ ‫ى‬i"" ‫ا‬ ‫ل‬ "" c ‫ا‬ 6"""""" ‫ا‬ ‫دى‬ """"""2 ‫ر‬ """") w """"5 ‫ن‬ ‫ا‬ 5‫ت‬ "9A ‫اب‬ rGolden cal 100ml Calcium" & j 4‫وا‬ j•"""""""""""""""""""""" $ ‫م‬ L ‫ا‬ ‫ى‬i"" ‫ا‬ ‫ل‬ "" c ‫ا‬ 6"""""" ‫ا‬ ‫دى‬ """"""2 ‫ر‬ """") w """"5 ‫ن‬ ‫ا‬ 7.50‫ت‬ "9A‫اب‬ rCalci cal
  • 41. ٤٠| P a g e Calcium carbonate 500mg Adult 500mg 1-2times after meals Children 250- 500mg daily •"""""""""""""""""""""" $ ‫م‬ """""""""""" L ‫ا‬ """"" ‫ا‬ ‫ء‬ """"" 3‫ا‬ -? """"""""" B2 """"""L5 6""""""9 ‫ن‬ ‫ا‬2 # 3‫ت‬ "9A12 cap - 2'‫آ‬ ‫ت‬ Calcimate 500 500mg of calcium Adult 500mg 1-2times after meals Children 250- 500mg daily •"""""""""""""""""""""" $ ‫م‬ """""""""""" L ‫ا‬ """"" ‫ا‬ ‫ء‬ """"" 3‫ا‬ -? """"""""" B2 """"""L5 6""""""9 2 # ‫ن‬ ‫ا‬ 6‫ت‬ "9A‫اص‬ *‫أ‬ 10 TAB Bone-cal *Calcium carbonate =700mg *calcium 180mg Adult 500mg 1-2times after meals Children 250- 500mg daily •"""""""""""""""""""""" $ ‫م‬ """""""""""" L ‫ا‬ """"" ‫ا‬ ‫ء‬ """"" 3‫ا‬ -? """"""""" B2 """"""L5 6""""""9 2 # ‫ن‬ ‫ا‬ 15‫ت‬ "9A‫اص‬ *‫أ‬ 30 TAB marcal
  • 42. ٤١| P a g e
  • 43. ٤٢| P a g e Cod liver oil ‫ت‬ I ‫ا‬ '‫آ‬ D& 1cap _ 1-2times daily _‫ا‬s g ( ! ‫ر‬ = ' & ‫د‬ @" "0 @" ",»‫د‬« #K K 2& T" % ) =9K P , ‫م‬ " 2 ! ‫ا‬ ‫م‬ Y ‫ا‬ ‫ن‬ 9%v‫وا‬ 22‫ت‬ "9A- 2'‫آ‬ ‫ت‬ 120 cap Seven seas Cod liver oil +vit a.d3.c 1 cap _ 1- 2times daily U 07 0"‰ ‫ا‬ C 2 ‫ا‬ 29‫ت‬ "9A- 2'‫آ‬ ‫ت‬ 20 cap Ultranyl Cod liver oilAdult 1 cap _ 1-2times daily U 07 0"‰ ‫ا‬ C 2 ‫ا‬ 28‫ت‬ "9A- 2'‫آ‬ ‫ت‬ 20 capCod liver oil
  • 44. ٤٣| P a g e Cod liver oil 100mg Adult 1cap _ 1- 2times daily _‫ا‬s g ( ! ‫ر‬ = ' & ‫د‬ @" "0 @" ",»‫د‬« #K K 2& T" % ) =9K P , ‫م‬ " 2 ! ‫ا‬ ‫م‬ Y ‫ا‬ ‫ن‬ 9%v‫وا‬ 14,90‫ت‬ "9A- 2'‫آ‬ ‫ت‬ 20 cap Fort sea vitA,c,d,omega 3,EPA.DHA 2.5:5ml.2-3 times daily according to kids edge 0"‰ ‫ا‬ U 07 C 2 ‫ا‬ 14,90‫ت‬ "9A120ml. ‫اب‬ r High sea 120ml Vit.A4600i.u Vit D380i.u C52mg 2.5:5ml.2-3 times daily according to kids edge 0"‰ ‫ا‬ U 07 C 2 ‫ا‬ 13,90‫ت‬ "9A120ml ‫اب‬ r Halorang 120ml
  • 45. ٤٤| P a g e
  • 46. ٤٥| P a g e Lidocaine hcl 40mg MK 6: ‫"%ج‬"""""""""" 6"""""""""""9 ‫ن‬ """"""""""" ‫ا‬١-٥ 6""""""""" ‫ت‬ """"""""".! G """""""""""""""""""""""dw ‫ا‬ G"""""""""""""""" c . ‫ا‬- 3 """"""" ‫ا‬ ‫اء‬ """""""42 ‫"%ل‬"""""""""""""""""w١-٢ G #‫د‬ ‫ر‬ ‫آ‬ ( '* ‫زرع‬ ‫او‬ @ CI ‫ا‬ ( '* ‫او‬ ‫ن‬ 9 %-‫ا‬ @ Š# ‫ا‬ ‫او‬ "6 ‫ا‬ ‫ر‬ ‫آ‬ , ‫ل‬s ‫ا‬ "# K !0 ‫ا‬ T"6# 8‫ت‬ "9ASPRA Y ‫خ‬ LIDO SPRAY Lidocaine 10%MK 6: 6"""""""""""9‫"%ج‬"""""""""" ‫ن‬ """"""""""" ‫ا‬١-٥ 6""""""""" ‫ت‬ """"""""".! G """""""""""""""""""""""dw ‫ا‬ G"""""""""""""""" c . ‫ا‬- 3 """"""" ‫ا‬ ‫اء‬ """""""42 ‫"%ل‬"""""""""""""""""w١-٢ G #‫د‬ ‫ر‬ ‫آ‬ ( '* ‫زرع‬ ‫او‬ @ CI ‫ا‬ ( '* ‫او‬ ‫ن‬ 9 %-‫ا‬ @ Š# ‫ا‬ ‫او‬ "6 ‫ا‬ ‫ر‬ ‫آ‬ , ‫ل‬s ‫ا‬ "# K !0 ‫ا‬ T"6# ١٠‫ت‬ "9ASPRA Y ‫خ‬ Lidocaine SPRAY Lidocaine 5%MK A: ‫"%ج‬"""""""""" 6"""""""""""9 ‫ن‬ """"""""""" ‫ا‬١-٥ 6""""""""" ‫ت‬ """"""""".! G """""""""""""""""""""""dw ‫ا‬ G"""""""""""""""" c . ‫ا‬- 3 """"""" ‫ا‬ ‫اء‬ """""""42 ‫"%ل‬"""""""""""""""""w١-٢ G #‫د‬ ‫ر‬ ‫آ‬ ( '* ‫زرع‬ ‫او‬ @ CI ‫ا‬ ( '* ‫او‬ ‫ن‬ 9 %-‫ا‬ @ Š# ‫ا‬ ‫او‬ "6 ‫ا‬ ‫ر‬ ‫آ‬ , ‫ل‬s ‫ا‬ "# K !0 ‫ا‬ T"6# 2.40‫ت‬ "9A5‫ه‬LIDOSINE
  • 47. ٤٦| P a g e Lidocaine 2%MK A: ‫"%ج‬""""""""" 6""""""""""9 ‫ن‬ """"""""""" ‫ا‬١-٥ 6""""""""" ‫ت‬ """"""""".! G """""""""""""""""""""""dw ‫ا‬ G"""""""""""""""" c . ‫ا‬- 3 """"""" ‫ا‬ ‫اء‬ """""""42 ‫"%ل‬"""""""""""""""""w١-٢ G #‫د‬ S 2 ‫ا‬ U073‫ت‬ "9AGelLIGNOCAINE Lidocaine 10%MK A: ‫"%ج‬""""""""" 6""""""""""9 ‫ن‬ """"""""""" ‫ا‬١-٥ 6""""""""" ‫ت‬ """"""""".! G """""""""""""""""""""""dw ‫ا‬ G"""""""""""""""" c . ‫ا‬- 3 """"""" ‫ا‬ ‫اء‬ """""""42 ‫"%ل‬"""""""""""""""""w١-٢ G #‫د‬ ‫ر‬ ‫آ‬ ( '* ‫زرع‬ ‫او‬ @ CI ‫ا‬ ‫ن‬ 9 %-‫ا‬( '* ‫او‬ @ Š# ‫ا‬ ‫او‬ "6 ‫ا‬ ‫ر‬ ‫آ‬ , ‫ل‬s ‫ا‬ "# K !0 ‫ا‬ T"6# 10‫ت‬ "9ASPRA Y ‫خ‬ LIGNOCAINE
  • 48. ٤٧| P a g e Lidocaine 10%MK A: ‫"%ج‬""""""""" 6""""""""""9 ‫ن‬ """"""""""" ‫ا‬١-٥ 6""""""""" ‫ت‬ """"""""".! G """""""""""""""""""""""dw ‫ا‬ G"""""""""""""""" c . ‫ا‬- 3 """"""" ‫ا‬ ‫اء‬ """""""42 ‫"%ل‬"""""""""""""""""w١-٢ G #‫د‬ ‫ر‬ ‫آ‬ ( '* ‫زرع‬ ‫او‬ @ CI ‫ا‬ ( '* ‫او‬ ‫ن‬ 9 %-‫ا‬ Š# ‫ا‬@ ‫او‬ "6 ‫ا‬ ‫ر‬ ‫آ‬ , ‫ل‬s ‫ا‬ "# K !0 ‫ا‬ T"6# 10‫ت‬ "9ASPRA Y ‫خ‬ LIGNORAL Lidocaine 10%MK A: ‫"%ج‬""""""""" 6""""""""""9 ‫ن‬ """"""""""" ‫ا‬١-٥ 6""""""""" ‫ت‬ """"""""".! G """""""""""""""""""""""dw ‫ا‬ G"""""""""""""""" c . ‫ا‬- 3 """"""" ‫ا‬ ‫اء‬ """""""42 ‫"%ل‬"""""""""""""""""w١-٢ G #‫د‬ ‫ر‬ ‫آ‬ ( '* ‫زرع‬ ‫او‬ @ CI ‫ا‬ ( '* ‫او‬ ‫ن‬ 9 %-‫ا‬ @ Š# ‫ا‬ ‫او‬ "6 ‫ا‬ ‫ر‬ ‫آ‬ , ‫ل‬s ‫ا‬ "# K !0 ‫ا‬ T"6# 44.75‫ت‬ "9ASPRA Y ‫خ‬ Xylocaine
  • 49. ٤٨| P a g e
  • 50. ٤٩| P a g e Hydrocortisone ‫ات‬ &‫و‬ 2 ‫ا‬ @ ‫ه‬ ( & ‫وه‬ & zC ‫ا‬ $9 ‫او‬ R0y #K 6 %-‫ا‬ @ & ‫ا‬ S& ? @K ‫ت‬ ‫ز‬ 6 ‫ا‬ , "c ‫ا‬ K 9 ‫ا‬ " & @"), !I ‫ا‬ @" 0 z " &Z‫وا-آ‬ ‫او‬ 0 z ‫ا‬ , '7 A 5.50‫ت‬ "9A5& ‫آ‬ 10gm Hydrocortisone 1% 1-Lidocaine ‫ر‬ 2-aminacrine A highly fluorescent anti- infective dye used clinically as a topical antiseptic and experimentally as a mutagen, 3-ethanol ‫ة‬ / ‫دة‬ ‫آ‬ ‫م‬ 2& M" 4-sucrose , - & !% j‫د‬ #4 5 ? 5-saccrine , - & !% j‫د‬ #4 5 ? " & @")‫ن‬ 9 %-‫ا‬ 5 ‫ا‬ @"9 2 ‫ا‬ ‫ء‬ 9+‫ا‬ 7‫ت‬ "9AGelDentinox teething gel Acyclovir M"%‫و‬ "0 ‫ا‬ ‫دات‬ ‫ا‬ `‫أآ‬ (!z ‫م‬ 2& ،ًK "r ‫وى‬ K ‫ج‬ ‫ص‬ y p"2' ‫ا‬ U ‫ا‬ ‫وس‬ ", " & ‫ات‬ $ ‫ار‬‫ج‬ ‫م‬ 2& ‫وي‬ K P ‫ا‬ U " ‫ا‬ #6 ‫ا‬ T" =)، 5 0 ‫ا‬،M" zg|‫ا‬ M"? ‫ا‬ 4.5"9ACreamAcyclovir 5%
  • 51. ٥٠| P a g e Acyclovir ‫دات‬ ‫ا‬ `‫أآ‬ M"%‫و‬ "0 ‫ا‬ ،ًK "r ‫ص‬ y (!z ‫م‬ 2& ‫وس‬ ", ‫وى‬ K ‫ج‬ p"2' ‫ا‬ U ‫ا‬ " & ‫ات‬ $ ‫ار‬‫ج‬ ‫م‬ 2& ‫وي‬ K P ‫ا‬ U " ‫ا‬ #6 ‫ا‬ T" =)، 5 0 ‫ا‬،M" zg|‫ا‬ M"? ‫ا‬ 12.5"9A‫ت‬Creamzovirax 5% Chlorzoxaze ‫زون‬ 2‫رزوآ‬ #! ‫ا‬ Chlorzoxazone ‫ت‬ "ِy ُ @ ‫ه‬ (!" ‫وا‬ ‫ت‬ ‫ا‬ (َ َ) P ‫ا‬ P Y ‫ا‬ ً&Z‫آ‬ centrally acting skeletal muscle relaxants. Paracetamol ‫ل‬ 6 ‫ا‬ $ %‫وا‬ @! 2 j‫ار‬ I# R, y‫و‬، " & ‫ات‬ ‫ث‬ +p % , ‫ت‬ # z ‫ا‬ 4 Y ‫ا‬ o0 ‫ا‬ ‫ت‬ 12"9A‫ت‬20 ‫ت‬ 4‫آ‬ Myolgin PEPPERMIN T OIL+EUCAL YPTUS OIL+THYME EXT. " & ‫ات‬ ‫ث‬ +z ‫ا‬ ‫-ت‬ I , # ‫ا‬ ‫ت‬ K @"!0 ‫ا‬ 24"9A5& ‫آ‬Relax massage cream
  • 52. ٥١| P a g e